CORONA Main Coronavirus thread

Heliobas Disciple

TB Fanatic

(fair use applies)


COVID dropped to 4th leading cause of death in US last year

By MIKE STOBBE
yesterday

NEW YORK (AP) — U.S. deaths fell last year, and COVID-19 dropped to the nation’s No. 4 cause, the Centers for Disease Control and Prevention reported Thursday.

COVID-19 deaths trailed those caused by heart disease, cancer and injuries such as drug overdoses, motor vehicle fatalities and shootings. In 2020 and 2021, only heart disease and cancer were ahead of the coronavirus.

U.S. deaths usually rise year-to-year, in part because the nation’s population has been growing. The pandemic accelerated that trend, making 2021 the deadliest in U.S. history, with more than 3.4 million deaths. But 2022 saw the first drop in deaths since 2009.

The 2022 tally was about 3.3 million — a 5% decline from 2021 but still much higher than in the years before the pandemic. The CDC cautioned that last year’s numbers are preliminary and may change a little after further analysis.

Coronavirus-associated death rates fell for nearly all Americans. The virus was deemed the underlying cause of about 187,000 U.S. deaths last year, accounting for about 6% of deaths. The highest COVID-19 death rates were in the South and in an adjacent region that stretches west to Texas, Oklahoma and New Mexico, the CDC said.

The death rates for heart disease and cancer increased during the pandemic, the CDC said. The cancer death rate had been falling for 20 years before COVID-19 hit.

The CDC report indicated a slight decline in the number of injury deaths last year, falling to about 218,000 from about 219,500 the year before. That would be a surprise, given recent trends in rising drug overdose and gun deaths.

CDC officials noted that number could rise. Death certificate data for injury deaths tends to take longer because many involve police investigations.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


COVID vaccine protection against infection drops after 6 months, protection against severe disease strong: Study
MARY KEKATOS - ABC News
Thu, May 4, 2023, 11:57 AM EDT

COVID-19 vaccine effectiveness against omicron infection fell dramatically after six months for people who only got their primary series, according to a new analysis published Wednesday.

The study may not accurately reflect vaccine effectiveness in the United States because researchers included many of the most common vaccines used around the world, including Pfizer-BioNTech, Moderna, AstraZeneca and Sinovac.

The researchers, however, did not look at the updated bivalent vaccines that target the original strain of the virus as well as BA.4 and BA.5, which are subvariants of omicron.

Meanwhile, scientists emphasize that vaccines are still working to significantly reduce the risk of hospitalization and death. Scientists no longer expect vaccines to offer good protection against mild infection since the evolution of new variants, nor is this as important due to the fact that most Americans have some level of underlying immunity.

For the analysis, published in JAMA Network Open, the team examined 40 studies -- a combination of articles and reviews published in peer-reviewed journals and preprints.

After receiving a primary series, protection against symptomatic disease decreased from 52.8% at one month after the last dose to 14.3% at six months to 8.9% at nine months.

When it came to vaccine effectiveness against overall infection, protection fell from 44.4% at one month to 20.7% at six months to 13.4% at nine months.

There were some differences in vaccine products from Pfizer and Moderna; they had higher effectiveness than the AstraZeneca and Sinovac vaccines.

Dr. John Brownstein, an epidemiologist and chief innovation officer at Boston Children's Hospital who was not involved in the study, said the results are not surprising because researchers have known about waning effectiveness for quite some time.

"However this study provides important insights into the specific effectiveness of the original monovalent vaccines against omicron and highlights the importance of the updated bivalent booster in providing additional protection," said Brownstein, an ABC News contributor.

Studies from the Centers for Disease Control and Protection show that the updated bivalent boosters enhance levels of protection.

One study found the bivalent booster slashed the risk of visiting an emergency department, urgent care facility or hospital due to COVID-19 by at least half for U.S. adults.

Another showed the bivalent booster provided additional protection against symptomatic infection with the two variants of omicron currently circulating, XBB and XBB.1.5, for at least three months in those who received two to four doses of the original vaccine.

"While effectiveness against infection is an important metric, effectiveness against severe disease, hospitalization and death are crucial metrics when evaluating the overall effectiveness of COVID vaccines, as these outcomes have the most significant impact on public health," Brownstein said.

The analysis also looked at protection when receiving the original booster dose. Levels of protectiveness increased but eventually waned as well.

Against infection, booster effectiveness fell from 55.4% at one month to 28.9% at nine months. Against symptomatic disease, effectiveness declined from 60.4% at one month to 13.3% at nine months.

Brownstein said it's important to reiterate that vaccination is still very important -- to protect both ourselves and those who are at risk of severe disease -- and to not interpret the study to mean vaccines aren't effective.

As of March 19, the latest date for which CDC data is available, COVID-19 cases were 81.11 per 100,000 among unvaccinated people compared to 26.66 per 100,000 for those vaccinated without the updated booster and 25.81 per 100,000 for those vaccinated with the updated booster.

Death rates as of Feb. 26, similarly, had a large gap with 1.07 per 100,000 deaths for those unvaccinated, 0.21 per 100,000 for those vaccinated without the updated booster and 0.19 per 100,000 for those vaccinated with the updated booster.

"The findings from this study shouldn't detract from the importance of vaccination," Brownstien said. "While the effectiveness of vaccines against omicron infection may wane over time, vaccines still provide significant protection against severe disease, hospitalization and death."

He added, "Additionally, booster doses can help maintain protection against the virus especially when they are more closely matched to circulating variants."
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Public health leaders warn dwindling COVID data risks less preparation for 'the next outbreak'
SASHA PEZENIK and CHEYENNE HASLETT - ABC News
Thu, May 4, 2023, 8:18 PM EDT

While COVID-19 ebbs -- and many of the pandemic-era policies on surveillance data and funding wind down with it -- the nation's public health leaders warned senators on Thursday that a return to "normal" should not mean forgetting the hard lessons learned over the last three years.

When the federal government's public health emergency expires next week, COVID-19 data collection tools will also end. Those tools have been described as vital to staying vigilant and preparing for emerging health threats.

"Infectious disease threats have been emerging at an increased pace and are increasingly complex," Centers for Disease Control and Prevention Director Rochelle Walensky told the Senate Health, Education, Labor, and Pensions (HELP) Committee. "These diseases don't respect national or state borders, and the increased frequency of outbreaks means that we should not be asking if we will face another serious public health threat -- but when."

Though "for many life has turned to normal after three years of COVID-19," Walensky said it's the mission of public health to "remain response-ready to protect Americans from any resolving or emerging health threat," which can only be done by "actively supporting the core capabilities of public health."

Thursday's hearing was part of the process to reauthorize the Pandemic and All-Hazards Preparedness Act, which was first signed into law in 2006 and has been regularly reauthorized since then.

"The approaching end of the public health emergency once again reminds us that policy changes and funding are essential to the readiness of future bio-threats. The CDC will continue to closely monitor COVID-19 and provide the information to which we have access," Walensky said.

She and other panelists emphasized that caveat: The limited access to data that comes along with a return to "normal" threatens to kneecap future surveillance efforts.

"We will adapt to limitations and utilize tried-and-true systems to monitor other respiratory diseases, to keep our eye on COVID-19," Walensky said, "but there are data we will no longer have available because they will no longer be submitted to us. For example, certain data for a national picture of health disparities both for race and ethnicity and along urban and rural lines."

"We will make do," the CDC director said. "However this should worry us all, primarily because of what it says about the visibility we will have into the next outbreak. We will be back to square one -- having to build and negotiate surveillance capacity while we fight a pathogen."

Dawn O'Connell, the U.S. Department of Health and Human Services' assistant secretary for preparedness and response, said that the U.S. actually was more prepared for COVID-19 than it would've been for other types of pandemics because of two prior respiratory outbreaks.

Neglecting to further that work would put the country at a big risk, O'Connell said.

"This is one of my biggest worries, is that we are losing time in preparing for the next pandemic," she said. "I know it doesn't feel like it, but the one place we were lucky when it came to the coronavirus is we had already done a lot of the early work on that because of SARS and MERS. We need to get the same head start."

That's something some senators looked to explicate in their line of questioning, with Sen. Bernie Sanders, I-Vt., interjecting: "Are you telling us that we have not done the kind of work you would like to see done in preparation for what might be coming?"

"Correct," O'Connell said.

Another tragedy briefly cast a shadow over Thursday's hearing, as Walensky opened her remarks by noting that one of the CDC's employees was killed Wednesday in a mass shooting in Atlanta.

Amy St. Pierre "was a valued member of our team at the Division of Reproductive Health where she worked every day to save the lives of mothers and infants," Walensky said.
 

Heliobas Disciple

TB Fanatic
(fair use applies)



What really killed COVID-19 patients: It wasn't a cytokine storm, suggests study
by Northwestern University
May 4, 2023

Secondary bacterial infection of the lung (pneumonia) was extremely common in patients with COVID-19, affecting almost half the patients who required support from mechanical ventilation. By applying machine learning to medical record data, scientists at Northwestern University Feinberg School of Medicine found that secondary bacterial pneumonia that does not resolve was a key driver of death in patients with COVID-19. It may even exceed death rates from the viral infection itself.

The scientists also found evidence that COVID-19 does not cause a "cytokine storm," so often believed to cause death.

The study was recently published in the Journal of Clinical Investigation.

"Our study highlights the importance of preventing, looking for and aggressively treating secondary bacterial pneumonia in critically ill patients with severe pneumonia, including those with COVID-19," said senior author Dr. Benjamin Singer, an associate professor of medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine pulmonary and critical care physician.

The investigators found nearly half of patients with COVID-19 develop a secondary ventilator-associated bacterial pneumonia.

"Those who were cured of their secondary pneumonia were likely to live, while those whose pneumonia did not resolve were more likely to die," Singer said. "Our data suggested that the mortality related to the virus itself is relatively low, but other things that happen during the ICU stay, like secondary bacterial pneumonia, offset that."

The study findings also negate the cytokine storm theory, said Singer, also the Lawrence Hicks Professor of Pulmonary Medicine at Feinberg.

"The term 'cytokine storm' means an overwhelming inflammation that drives organ failure in your lungs, your kidneys, your brain and other organs," Singer said. "If that were true, if cytokine storm were underlying the long length of stay we see in patients with COVID-19, we would expect to see frequent transitions to states that are characterized by multi-organ failure. That's not what we saw."

The study analyzed 585 patients in the intensive care unit (ICU) at Northwestern Memorial Hospital with severe pneumonia and respiratory failure, 190 of whom had COVID-19. The scientists developed a new machine learning approach called CarpeDiem, which groups similar ICU patient-days into clinical states based on electronic health record data. This novel approach, which is based on the concept of daily rounds by the ICU team, allowed them to ask how complications like bacterial pneumonia impacted the course of illness.

These patients or their surrogates consented to enroll in the Successful Clinical Response to Pneumonia Therapy (SCRIPT) study, an observational trial to identify new biomarkers and therapies for patients with severe pneumonia. As part of SCRIPT, an expert panel of ICU physicians used state-of-the-art analysis of lung samples collected as part of clinical care to diagnose and adjudicate the outcomes of secondary pneumonia events.

"The application of machine learning and artificial intelligence to clinical data can be used to develop better ways to treat diseases like COVID-19 and to assist ICU physicians managing these patients," said study co-first author Dr. Catherine Gao, an instructor in pulmonary and critical care medicine at Feinberg and a Northwestern Medicine physician.

"The importance of bacterial superinfection of the lung as a contributor to death in patients with COVID-19 has been underappreciated because most centers have not looked for it or only look at outcomes in terms of presence or absence of bacterial superinfection, not whether treatment is successful or not," said study co-author Dr. Richard Wunderink, who leads the Successful Clinical Response in Pneumonia Therapy Systems Biology Center at Northwestern.

The next step in the research will be to use molecular data from the study samples and integrate it with machine learning approaches to understand why some patients go on to be cured of pneumonia and some don't. Investigators also want to expand the technique to larger datasets and use the model to make predictions that can be brought back to the bedside to improve the care of critically ill patients.
 

vector7

Dot Collector
BREAKING: COVID-19 Vaccine can Cause Blindness

A group of scientists recently conducted a study that investigated a potential link between COVID-19 vaccines and a type of eye condition known as retinal vascular occlusion.

This condition occurs when blood vessels in the eye become blocked, leading to potential vision loss. The study was published in the journal Nature. The scientists analyzed a cohort of individuals who had received the COVID-19 vaccine and compared them to those who had not.

They discovered that the risk of retinal vascular occlusion was higher in those who had been vaccinated compared to those who had not. The risk was found to be highest in the first few weeks after vaccination but could last for up to 12 weeks.

Furthermore, the incidence of retinal vascular occlusion was significantly higher in those who received the vaccine after 2 years, with an overall hazard ratio of 2.19. This means that vaccinated persons are 2 times more likely to be inflicted with blindness.

Additionally, 12 weeks after being vaccinated, the potential for blindness was higher for all ages. The research also revealed that individuals who had received the BNT162b2 and mRNA-1273 vaccines had a significantly increased risk of developing retinal vascular occlusion 2 years after vaccination.

It is important to note that the risk of blindness caused by the vaccine did not vary based on the brand or dose of the vaccine. This means that all COVID-19 vaccines were associated with this side effect.
View: https://twitter.com/MarioNawfal/status/1654517924055379969?s=20
 

Heliobas Disciple

TB Fanatic
(fair use applies)


'I declare COVID over': World Health Organization boss says pandemic is no longer a global health emergency
By Mansur Shaheen Deputy Health Editor For Dailymail.Com and Associated Press
Updated: 12:20 EDT, 5 May 2023

  • The global health leaders said the virus no longer constitutes an emergency
  • The UN organization fell short of declaring the pandemic over all-together

Covid is no longer a global emergency, according to leaders at the World Health Organization (WHO) — a symbolic moment the pandemic is near its end.

Tedros Adhanom Ghebreyesus, director-general of the UN health agency, said Friday: 'It's with great hope that I declare COVID over as a global health emergency.'

However, he stopped short of declaring the pandemic over, warning that the virus still posed a threat in developing countries that have not had access to vaccines.

It comes as the final pandemic restrictions in the US are set to end Thursday months after President Joe Biden declared the pandemic 'over' for America.

The pandemic, which triggered once-unthinkable lockdowns, upended the global economy, and killed at least 7million people across the world.

At the briefing Friday, Dr Tedros said the pandemic is likely responsible for around 20million deaths — due to reporting issues and testing inconsistencies.

'It isn't a snap decision. It's something we came up with over time,' Dr Maria Van Kerkhove, an American infectious disease specialist at the WHO, said in response to a question about why the agency made this decision so late.

Professor Didier Houssin, a WHO member from France, said the agency first considered lifting the emergency in January.

However, a massive Covid surge in China around the new year that triggered fears of a new strain with traits that had never been seen before made them reconsider.

The health agency first declared Covid an international crisis on January 30, 2020. At that point, no major outbreaks had been recorded outside of China.

However, the WHO leaders now say it is time for countries to treat Covid as they do other infectious diseases.

'The ending of the emergency is emphatically not the end of Covid as a public health problem,' Prof Mark Woolhouse of the University of Edinburgh, in Scotland, said.

'Rather, it is a recognition that we are no longer seeing major surges in infections, severe illness and death.

'Hopefully, the large wave in China at the beginning of the year – precipitated by that country's abrupt exit from their Zero Covid strategy – will be the last event of such magnitude.'


Dr Michael Head, a senior research fellow at the University of Southampton, said: 'One slightly counter-intuitive aspect is that the WHO has downgraded COVID-19 from a public health emergency, yet the sustained multi-country transmission means it still meets most widely used definitions of a 'pandemic'.

'However, we are clearly in a different phase of handling COVID-19, the impact of the virus is clearly much less than it was, and the WHO decision is reasonable.'

More than three years later, the virus has caused an estimated 764million cases globally and about 5billion people have received at least one dose of vaccine.

In the US, the public health emergency declaration made regarding COVID-19 is set to expire on May 11. President Joe Biden ended the Covid national emergency on April 11.

On this day, wide-ranging measures to support the pandemic response, including vaccine mandates, will end.

Many other countries, including Germany, France and Britain, dropped many of their provisions against the pandemic last year.

When Tedros declared COVID-19 to be an emergency in 2020, he said his greatest fear was the virus' potential to spread in countries with weak health systems he described as 'ill-prepared.'

In fact, some of the countries that suffered the worst COVID-19 death tolls were previously judged to be the best-prepared for a pandemic, including the US and the UK.

An estimated 1.1million Americans died from Covid, the most of any nation. In the UK, more than 200,000 deaths have been logged.

Dr Kerkhove said the true number of deaths from Covid could be much higher than recorded.

'We know its far higher than the 7million deaths that have been reported,' the expert said.

The US also recorded more cases than any other nation, eclipsing the 100million mark. An estimated 24million were suffered in the UK.

WHO decided to lower its highest level of alert on Friday, after convening an expert group on Thursday.

The UN agency doesn't 'declare' pandemics but first used the term to describe the outbreak in March 2020, when the virus had spread to every continent except Antarctica.

That decision came long after many other scientists had said a pandemic was already underway.

The WHO is the only agency mandated to coordinate the world's response to acute health threats, but the organization faltered repeatedly as the coronavirus unfolded.

It recommended against members of the public wearing masks to protect against Covid for months at the start of the pandemic. It later began to recommend the face coverings.

Numerous scientists also slammed WHO's reluctance to acknowledge that Covid was frequently spread in the air and by people without symptoms.

Dr Tedros was a vociferous critic of rich countries who hoarded the limited supplies of Covid vaccines, warning that the world was on the brink of a 'catastrophic moral failure' by failing to share shots with poor countries.

Most recently, the WHO has been struggling to investigate the origins of the virus.

After a weeks-long visit to China, WHO released a report in 2021 concluding that COVID-19 most likely jumped into humans from animals, dismissing the possibility that it originated in a lab as 'extremely unlikely.'

But the UN agency backtracked the following year, saying 'key pieces of data' were still missing and that it was premature to rule out that Covid might have ties to a lab.

A panel commissioned by WHO to review its performance criticized China and other countries for not moving quicker to stop the virus and said the organization was constrained both by its limited finances and inability to compel countries to act.

The WHO decision means little to the way that some nations will operate coming out of the pandemic.

In the US, the Covid emergency was ended last month, with the overall public health declaration set to end next week.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


EXCLUSIVE: Is a 'cryptic' Covid strain lurking in YOUR area? 32 never-before-seen variants have been detected in 13 states — and they are so mutated they could trigger 'concerning' outbreaks

By Mansur Shaheen Deputy Health Editor For Dailymail.Com
Updated: 18:26 EDT, 1 May 2023

  • Scientists have detected at least 32 cryptic lineages across the US
  • These strains are surviving for long periods of time within a single person
More than 30 extremely mutated, never-before-seen Covid strains are lurking in multiple US states, DailyMail.com can reveal.

A team of scientists from the University of Missouri has been tracking these so-called 'cryptic' variants by testing wastewater samples across the country.

They have detected 32 strains so far in 13 states — including New York, California and Florida — but say these cases are just the 'tip of the iceberg'.

The viruses are being harbored by people known as 'long-haulers', patients who struggle to clear Covid infection for months or even years, giving the virus an unusually long window to mutate.

Dr Marc Johnson, the virologist at Missouri who is leading the research, warned the strains are so mutated they would instantly be classed 'variants of concern' if they were to start spreading.

'I assume the cryptic lineages are the tip of the iceberg,' Dr Johnson said.

'If there's this many long-term infections [we have found], how many are we not detecting.'

He believes more resources should be invested in finding these strains, saying: 'It would be worthwhile to figure out who has the infection and why.'

The scientist is unsure whether the patients shedding the novel variants are contagious or how they have managed to stay infected so long.

Dr Johnson does not think they are infectious. But he warns if the patients continue to harbor the viruses, there is a risk they acquire a mutation that allows them to spread rapidly through the population.

None of the patients carrying a cryptic lineage have been identified, and little is known about each of them.

In a report last year, Dr Johnson's team wrote that: 'The simplest explanation for the appearance of cryptic lineages in wastewater is that they are shed by immunosuppressed patients with persistent infections.'

Patients who harbor viruses for exceptionally long periods of time often have weakened immune systems, which means their body struggles to clear the virus.

Many scientists believe the Alpha, Delta and Omicron variants all emerged this way.

They likely all have some sort of genetic mutation in common that allows the virus to evade their immune system for so long.

'I'm guessing there is something similar about these patients but it might not be obvious,' he said.

He believes that one in every 4million people are harboring one of these strains, or have in the past. This would mean there are about 80 cryptic lineages circulating.

So far, ten have been detected in New York City — more than double any individual state.

The virologist said that this is because the city is so densely populated that wastewater samples from the big apple include more people than in other areas.

As a result, it is easier to detect these strains in the Big Apple than anywhere else.

Four have been detected in California, and one to three lineages have been found 11 other scattered states.

These include: Colorado, Florida, Kentucky, Missouri, Montana, New Jersey, Ohio, Oklahoma, Texas, Virginia and Wisconsin.

'I wasn't looking for them; we just started sequencing things that didn't match up,' Dr Johnson said of his first encounters with the lineages.

Wastewater sequencing is a tool used by virologists and public health experts to gather data on the prevalence of different viruses in a local community.

Scientists will gather samples of sewer water and test it to look for different strains.

Because a person will shed the virus in the stool before they suffer symptoms, this type of surveillance can allow public health experts to get ahead of some outbreaks.

One of those strains was found in Central Ohio, where Dr Johnson's team believes they have found a person who has been infected with the virus for at least two years.

This person regularly commutes between Columbus — the state's largest city — and Washington Court House, a small town of 15,000 40 miles southwest.

Researchers have found the same cryptic lineage circulating between the two cities since at least March 2021.

This same lineage has not been detected anywhere else to the scientists' knowledge.

This specific pattern likely means the person lives in Washington Court House and commutes to Columbus.

It could be for work, but the patient could also be a student, as Columbus is home to Ohio State University — which has more than 66,000 students.

It is unclear how the person has harbored the virus for so long, but it is likely the virus has mutated within him to cause little complications.

Overall, there are likely only a few thousand people that meet these guidelines, a relatively small group to be sifted through.

In Spring 2022, Dr Johnson found a cryptic strain in Wisconsin. The afflicted person was shedding viral load at an exorbitant rate.

His team tested water in manholes in the area, and managed to track down where the load was coming from.

In late Summer 2022, they linked the strain to a toilet at a specific building, which employed many people who were coming to work each day. One of those employees is carrying the cryptic strain, Dr Johnson believes.

The business has agreed to allow Dr Johnson to collect stool samples from some employees to determine which one is carrying the strain.

The typical Covid case lasts for only a few days — and the maximum time someone should expect to be sick is two weeks.

Dr Johnson hopes that finding the people harboring these cases can allow scientists to learn more about the virus itself and whether these cryptic lineages are tied to the phenomenon of 'long Covid'.

'I assume the cryptic lineages are the tip of the iceberg. If there's this many long-term infections then how many more are we not detecting,' he explained.

'It would be worthwhile to figure out who has these infections and why.'

In March 2021, Dr Johnson first encountered a mysterious lineage when sequencing wastewater in Missouri.

His team discovered a strain of Covid they had never seen before. Over a month, they detected 12 samples of a strain with up to six mutations differing from the typically circulating strains.

When expanding their research, scientists would find six unknown lineages circulating in New York City, one in California and a second in Missouri over the coming months.

They would name them 'cryptic lineages', and went on a search to determine where they were coming from.

At first, the virologists thought the strains were circulating in animals. Rats were a simple answer because of how many are infesting New York City's sewers.

However, some strains showed RNA that was inconsistent with rodent infection and the mutations the viruses picked up were human 'immune escape mutations', meaning they would help it evade a person's immune system.

If rats were hosting the strains, they would not mutate to escape the human immune system.

Patients likely do not know they have Covid. Instead, they are either asymptomatic or suffering symptoms similar to a stomach infection.

These would include diarrhea, nausea, vomiting and other relatively-manageable symptoms.

In many cases the person will still be able to perform daily activities such as going to work or caring for their children.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Walensky Resigns as C.D.C. Director
In an announcement on Friday, the head of the beleaguered agency said she would step down in June. “We made this world a safer place,” she said.

By Apoorva Mandavilli and Noah Weiland
May 5, 2023 Updated 7:14 p.m. ET

Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, will step down from her position on June 30, she announced on Friday, capping a tumultuous tenure at the nation’s leading public health agency as it struggled to rein in the Covid-19 pandemic, the greatest threat to American well-being in decades.

Her departure comes as the administration contends with major vacancies in its Covid-19 response team. Dr. Ashish Jha, the White House’s Covid-19 coordinator, plans to leave his position this month, along with other key officials, including Dr. Nahid Bhadelia, a White House adviser on the global response. A new White House pandemic office has no leader or staffing.

The administration plans to end the public health emergency on May 11, closing major programs — like access to free tests — that had helped sustain Americans through the worst days of the pandemic.

But the virus has not disappeared. It is still killing roughly 1,000 Americans each week and hospitalizing even more. The leadership vacuum arrives at a precarious time.

In an agencywide meeting, Dr. Walensky admitted to having mixed emotions about her decision and broke down in tears, according to people who had been on a conference call with her.

“I took on this role with the goal of leaving behind the dark days of the pandemic and moving the C.D.C. — and public health — into a much better and more trusted place,” she said in a subsequent email to the agency’s staff.

Dr. Walensky did not respond to a request for comment. Senior administration officials and outside experts have said that Dr. Walensky struggled with an unwieldy leadership structure at the Department of Health and Human Services, of which the C.D.C. is a part. The agency’s relationship with the White House was sometimes tense, as her advice to the public sometimes seemed confusing or contradictory.

A person familiar with her thinking said that Dr. Walensky had also wearied of harassment from members of the public who were unhappy with pandemic restrictions and of long commutes between the C.D.C.’s offices in Atlanta and her home in Massachusetts.

Andy Slavitt, a key adviser on the White House Covid-19 team in 2021, praised Dr. Walensky’s efforts to do a job “that’s easy to criticize and tough to do.”

“You show up in an emergency status with a specific job to do,” he added. “It’s almost like a mission, with a beginning and end. Even though she was running an agency, running an agency during wartime is different than running an agency during peacetime.”

Public health experts said the news had come as a surprise, and some expressed disappointment that she was leaving.

“I think it is a loss for the C.D.C. and for the nation,” said Dr. Megan Ranney, the deputy dean for Brown University’s School of Public Health. “I know that it has not been easy, not just because of Covid but because of the politicization of science.”

Dr. Ranney said that she had received hate mail and personal attacks but that what she had experienced was “only the tip of the iceberg” compared with how Dr. Walensky had been treated.

Dr. Celine Gounder, a former adviser to the Biden administration who has known Dr. Walensky since 2004, said, “Her departure signals to me that the C.D.C. is more broken and the federal government’s commitment to public health is even weaker than I’d thought.”

Dr. Walensky grew up in Potomac, Md., in a family of respected scientists. She trained in medicine at Johns Hopkins University and, in 2001, joined the faculty at Harvard, where she developed a reputation as a rigorous researcher and a generous mentor.

Before her tenure as C.D.C. director, Dr. Walensky led the infectious diseases division at Massachusetts General Hospital, where she saw the pandemic’s devastation firsthand. She was noted for her work on health care policy, particularly in H.I.V.

But with little experience working in government and leading large institutions, Dr. Walensky was an unexpected choice to guide an agency with a staff of about 11,000 people.

Dr. Walensky took the helm of the beleaguered agency in January 2021. She had a near-impossible task ahead of her: restoring the reputation of the once-storied C.D.C. when public trust in the agency, and science more broadly, was fast ebbing.

The C.D.C. had been pilloried since the start of the pandemic for missteps in testing, changing advice on masking, and antiquated surveillance and data systems. Trump administration officials hectored the agency’s leaders, rewrote its guidance and meddled with its research reports, undermining the morale of scientists even as the crisis ballooned.

“She insisted that people act more promptly and in a more focused way, so she stimulated people to do things perhaps a little bit differently than they had,” said Dr. William Schaffner, an infectious diseases physician at Vanderbilt University who works closely with the agency.

“Morale within the C.D.C. distinctly improved under her leadership,” he added.

But the pandemic proved to be rough ground even for someone as respected and well-liked as Dr. Walensky. She was roundly criticized by experts for advising people to stop wearing their masks just weeks before the Delta variant of the coronavirus pummeled the nation.

And after shortening isolation requirements even as the Omicron variant brought the country to a standstill, she was accused of letting economic interests outweigh scientific caution.

Anne Sosin, who studies health equity at Dartmouth, said that Dr. Walensky had sometimes taken the fall for Biden administration decisions, but that she also could have done more to level with the public about the rationales for those decisions.

Still, Ms. Sosin added, “From the outside, it has sometimes appeared that Dr. Walensky has lacked the courage to say no to decisions that really undermined public health.”

Republicans in Congress repeatedly asked for her resignation and painted the agency as a failed institution in hearings on the pandemic. But some experts felt Dr. Walensky had done her best with an impossible hand.

“The public — and even health professionals — wanted consistency in message and messaging that was not possible, because Covid has simply never been a static threat,” said Dr. Jeremy Faust, an emergency medicine physician and health policy expert at Brigham and Women’s Hospital in Boston.

Dr. Daniel Pollock, who led Covid surveillance for a few months in 2020 and retired in November 2021 after 37 years at the agency, said: “The timing of this leadership transition is very problematic. I worked at C.D.C. under 10 different directors, and when they leave abruptly, for whatever reason, the ripple effects take a big toll.”

It was not immediately clear who would lead the C.D.C. after Dr. Walensky’s departure. Some scientists said Dr. Walensky’s successor should be a public health generalist attuned to social problems and how to run a large federal agency, not a physician-scientist like Dr. Walensky.

“This has to be a public health person,” said Katelyn Jetelina, an epidemiologist who writes a popular newsletter and has been advising the C.D.C. for the past year. “We think about treating millions of people at one time, rather than this initial training of one-on-one physician care.”

Despite the controversy surrounding her tenure, Dr. Walensky’s email to staff members on Friday suggested that she believed she had improved the agency’s standing.

“We collectively moved C.D.C. forward, reorganizing the agency and embarking on the necessary work to orient the enterprise toward public health action and foster accountability, timeliness and transparency in our work,” she said.

During her time at the C.D.C., Dr. Walensky noted, the agency administered more than 670 million Covid vaccine doses and provided guidance on immunization, social distancing and masking that “protected the country and the world from the greatest infectious disease threat we have seen in over 100 years.”

Dr. Walensky acknowledged the agency’s failings last year and promised to reorganize it, transforming its ability to respond quickly to public health crises. Some organizational changes have been announced, but it is unclear whether any of them have made a material difference in the C.D.C.’s work.

Among other changes, Dr. Walensky helped create an office that’s more organized and empowered to work with state and local health developments, said Dr. Joshua Sharfstein, vice dean for public health practice and community engagement at the Johns Hopkins University Bloomberg School of Health.

“It puts the agency in a position to have a vision for how the nation’s very convoluted public health system holds together,” he said. “One of the jobs as the director is going to be to take the structure that Dr. Walensky has left and use it.”

Under her leadership, Dr. Walensky said in her email to staff members, the agency bolstered its public health infrastructure and secured hundreds of millions of dollars to modernize the country’s data infrastructure.

She also declared racism a serious public health threat, she noted, and led the agency in its efforts to contain a multinational mpox outbreak, as well as the spread of Ebola in Uganda.

“We made this world a safer place,” Dr. Walensky said. “I have never been prouder of anything I have done in my professional career.”
 

Heliobas Disciple

TB Fanatic
(fair use applies)


US-funded Sudanese Biolab Seized By Militants​

Published on May 5, 2023
Written by Natalie Winters


Sudan’s National Public Health Laboratory – whose recent seizure by militants has prompted warnings of causing a “huge biological risk” – received financial and personnel support from U.S. government bodies including the Department of Defense, Centers for Disease Control and Prevention, and Dr. Anthony Fauci’s National Institutes of Health agency, War Room can reveal.

The stunning revelation follows Nima Saeed Abid, the World Health Organization (WHO) representative in Sudan, admitting the situation was “extremely dangerous” because “we have polio isolates in the lab, we have measles isolates in the lab, we have cholera isolates in the lab.”

U.S. federal funding has directly supported research conducted by researchers from the high-risk laboratory into cholera.

“There is a huge biological risk associated with the occupation of the central public health lab in Khartoum by one of the fighting parties,” he added.

The lab, which is based in the country’s capital Khartoum, is a recipient of support from a variety U.S. government agencies including the Department of Defense (DOD), Centers for Disease Control and Prevention(CDC), and United States Agency for International Development (USAID).

During Dr. Fauci’s tenure as a National Institutes of Health (NIH) agency leader, he also allocated funds to support research involving scientists from the controversial laboratory.

A pamphlet titled “CDC In South Sudan,” published in August of 2022, reveals the extent of the government agency’s involvement in the country.

“In May 2018, CDC supported establishment of the first viral load monitoring facility at South Sudan’s National Public Health Laboratory (NPHL),” explains a synopsis of the CDC’s involvement with the lab.

A key feature of the CDC’s involvement with the lab was “Laboratory Systems Strengthening,” with the agency noting:

“Since 2006, CDC has partnered with the Global Fund to support South Sudan’s NPHL by strengthening laboratory infrastructure, staffing, and technical capacity.”
“With technical support from CDC, the Ministry of Health developed and released consolidated national HIV treatment guidelines and five laboratory manuals and standard operating procedures for NPHL staff and HIV/AIDS program staff,” continues the CDC.

cdc1.png


Moreover, a research paper published in July 2022 – “Viral load scale-up in South Sudan: Strategic implementation of tools to monitor HIV treatment success among people living with HIV” – involving the controversial Sudanese laboratory counts financial support from the CDC through the President’s Emergency Plan for AIDS Relief.

The paper includes two researchers from the NPHL alongside four CDC researchers from the Divisions of Global HIV & TB and Healthcare Quality Promotion.

cdc2.png


The paper’s acknowledgment section also identifies the “US Agency for International [and] Development, US Department of Defense” for providing the researchers with “support,” though it fails to provide any further information.

FAUCI/NIH.​


National Institute of Allergy and Infectious Diseases (NIAID), the NIH agency previously run by Dr. Fauci, has also funded a research paper counting researchers from Sudan’s NPHL. Curiously, the 2017 paper – “Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses” – focuses on cholera in Sudan, which is one of the diseases flagged by the WHO as being affected by the seizure.

A researcher listed on the paper, Lul O. Deng, works for the Sudanese NPHL.

“This work was supported by The National Institute of Health (K08 AI100923 to D.T.L., R01 AI130378 to D.T.L., AI106878 to E.T.R., AI099243 and AI103055 to J.B.H.),” explains the paper.

The aforementioned grants all come from the NIAID during Fauci’s tenure and totals over 20 million dollars, as revealed in the breakdown below:

The Bill and Melinda Gates Foundation were also co-funders of the study.

cdc3.png


USAID.​


USAID increased its collaborations with the lab during COVID-19, with a press release revealing it “funded procurement of COVID-19 tests and provided equipment” and “designated regional laboratories to rapidly scale up testing capabilities.”

A WHO press release from 2018 also reveals the agency’s involvement with the NPHL:
‘Thanks to Global Fund, ECHO, CDC and USAID, South Sudan has made progress in building and strengthening the laboratory capacity to test and report results in a safe, secure, timely and reliable manner for outbreaks and emergencies, the challenging circumstances notwithstanding said Evans Liyosi, WHO Representative for South Sudan.
He noted that this development is in line with the expectations of the WHO Laboratory Improvement for Emergencies (LIFE) initiative and the International Health regulations, for vulnerable WHO member states including South Sudan.”

Deja Vu.​


The revelations about U.S. government involvement in Sudan’s NPHL follow similar scrutiny over support from a Hunter Biden-linked company for Ukrainian Biolabs working on “extremely dangerous pathogens.”

It also follows Dr. Fauci allocating millions of taxpayer dollars to support gain-of-function research on coronavirus strains strikingly similar to COVID-19 at the Wuhan Institute of Virology.

See more here warroom.org
 

Heliobas Disciple

TB Fanatic
(fair use applies)



COVID Vaccines Linked to Untreatable Eyeball Clots, Reveals Massive Study.

by Jack Montgomery
May 5, 2023

A major scientific journal has published research linking COVID vaccinations to retinal vascular occlusion, with vaccinated individuals at “significantly” greater risk of developing blood clots than unvaccinated individuals.

The paper published in Nature harvested data on some 95,156,967 people. Of those, 7.3 million met the criteria for inclusion in the study.

Controlling for confounding variables such as people on anticoagulants, certain contraceptives, and other medications, the researchers were left with 745,041 vaccinated and 3.8 million unvaccinated subjects to compare. They found that “two years after vaccination, the chances of all subtypes… of retinal vascular occlusion increased significantly in the vaccinated cohort.”

Retinal vein occlusion, or RVO, has generally been associated with “people with diabetes, and possibly high blood pressure, high cholesterol levels, or other health problems that affect blood flow,” according to the Cleveland Clinic.

It can be a very serious condition, sometimes leading to the formation of abnormal new blood vessels that can “cause pain and a dangerous increase in pressure inside the eye” or even blindness.

There is currently no treatment available that can unblock retinal veins, with treatments for the symptoms of RVO including things like injecting anti-vascular endothelial growth factor (VEGF) drugs and corticosteroids directly into the eyeball.

“The overall risk of retinal vascular occlusion in the vaccinated cohort was 2.19 times higher than that in the unvaccinated cohort at 2 years,” the Nature paper observed, with “no disparity was detected between brand and dose of vaccines.”

Nevertheless, they insisted that “[a]dditional research is required to draw a solid conclusion regarding the association between retinal vascular occlusion and COVID-19 vaccines.”

Henry Bair of the Byers Eye Institute, Stanford University School of Medicine, authored the study alongside a range of Taiwanese researchers from institutions such as the Chung Shan Medical University Hospital and the Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Do Not Get COVID Vaccine Shots in the Morning or in the Evening, Especially If You Are Young or Old!
Timing of the shot matters for COVID vaccine effectiveness, Nature says

Igor Chudov
May 5, 2023

Here’s a new article from Nature:

It turns out that “younger” and “older” people had significantly worse protection from Covid vaccine if vaccinated not precisely in the middle of the day.

So, vaccine science just explained why Covid vaccines are not working for so many people!

It’s not that the vaccines do not work, you see. Vaccines do work! However, the time of day for the shot was wrong, say scientists who wrote the Nature article. They should have known better and had it administered exactly at noon for everyone.

So, if you are younger or older, do not take Covid vaccine in the morning or evening! (my comment - do not take it at midday either)
 

Heliobas Disciple

TB Fanatic
ttps://medicalxpress.com/news/2023-05-features-covid-neurological-symptoms.html
(fair use applies)



Study identifies features of Long COVID neurological symptoms
by National Institutes of Health
May 6, 2023

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles and autonomic dysfunction. These data inform future studies to help explain persistent neurological symptoms in Long COVID. The findings, published in Neurology: Neuroimmunology & Neuroinflammation, may lead to better diagnoses and new treatments.

People with post-acute sequelae of COVID-19 (PASC), which includes Long COVID, have a wide range of symptoms, including fatigue, shortness of breath, fever, headaches, sleep disturbances, and "brain fog," or cognitive impairment. Such symptoms can last for months or longer after an initial SARS-CoV-2 infection. Fatigue and "brain fog" are among the most common and debilitating symptoms, and likely stem from nervous system dysfunction.

Researchers used an approach called deep phenotyping to closely examine the clinical and biological features of Long COVID in 12 people who had long-lasting, disabling neurological symptoms after COVID-19. Most participants had mild symptoms during their acute infection. At the NIH Clinical Center, participants underwent comprehensive testing, which included a clinical exam, questionnaires, advanced brain imaging, blood and cerebrospinal fluid tests, and autonomic function tests.

The results showed that people with Long COVID had lower levels of CD4+ and CD8+ T cells—immune cells involved in coordinating the immune system's response to viruses—compared to healthy controls. Researchers also found increases in the numbers of B cells and other types of immune cells, suggesting that immune dysregulation may play a role in mediating Long COVID.

Consistent with recent studies, people with Long COVID also had problems with their autonomic nervous system, which controls unconscious functions of the body such as breathing, heart rate, and blood pressure. Autonomic testing showed abnormalities in control of vascular tone, heart rate, and blood pressure with a change in posture. More research is needed to determine if these changes are related to fatigue, cognitive difficulties, and other lingering symptoms.

Taken together, the findings add to growing evidence that widespread immunological and autonomic nervous system changes may contribute to Long COVID. The results may help researchers better characterize the condition and explore possible therapeutic strategies, such as immunotherapy.
 

psychgirl

Has No Life - Lives on TB
(fair use applies)


Do Not Get COVID Vaccine Shots in the Morning or in the Evening, Especially If You Are Young or Old!
Timing of the shot matters for COVID vaccine effectiveness, Nature says

Igor Chudov
May 5, 2023

Here’s a new article from Nature:

It turns out that “younger” and “older” people had significantly worse protection from Covid vaccine if vaccinated not precisely in the middle of the day.

So, vaccine science just explained why Covid vaccines are not working for so many people!

It’s not that the vaccines do not work, you see. Vaccines do work! However, the time of day for the shot was wrong, say scientists who wrote the Nature article. They should have known better and had it administered exactly at noon for everyone.

So, if you are younger or older, do not take Covid vaccine in the morning or evening! (my comment - do not take it at midday either)
Do not take one at ANY time of the day lol !!
 

Old Goat

Contributing Member
Jim Stone May 8th:

The Covid op was carried out by fake nurses and doctors created by the DOD via a fake diploma program​


As it turns out, the DOD launched the Covid op and supported it with thousands of fake doctors and nurses who made the ventilator deaths happen.​

The DOD fakes then approached the hospitals for employment during a "massive nursing and doctor shortage". These doctors and nurses then went on to deny family access to their loved ones while they murdered them. Everyone ought to remember how the hospitals were just murdering people in the name of "covid" and it now appears there is a back story to how it was actually accomplished. This is the reason why hospitals got paid so much for every "covid death", to the tune of about $80,000 each. People who only intended to murder from the beginning were handed fake medical diplomas, and then proceeded to use the cover of "medicine" to do exactly that.

Now that the Covid hoax has fallen apart, HHS is going after the same people they paid all along to do it. It was HHS giving the huge payouts so HHS was definitely involved, but snakes eat snakes don't ya know, here is the cover story that's going to prevent the giant snakes at the top from being eaten. FINALLY some truth comes out, but obviously this is not the whole story. They'll try to end it with this though.

"On January 25, 2023, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), the FBI, and the Department of Justice carried out a multistate operation to apprehend the people involved in an alleged scheme to sell fraudulent nursing diplomas and transcripts.

The operation was named "Operation Nightingale" after Florence Nightingale, the founder of modern nursing who created the first science-based training for nurses. The HHS-OIG partnered with law enforcement to execute search warrants across five states:

Delaware, New York, New Jersey, Texas, Florida.

More than 7,600 aspiring registered nurses (RNs) and licensed practical nurses (LPNs) bought false diplomas to find work with unsuspecting healthcare providers in several states. The diploma represented that these individuals attended the college that provided the diploma and completed all the necessary coursework, so they were able to get their nursing licenses. Yet, they did not complete any classroom or clinical education.

My comment: Notice the careful wording, which makes the HHS and the FBI look like the good guys. Also,note the careful wording here that does not reveal how massive the op actually was, they have this limited to five states. But the bottom line is that this was happening in all 50 plus Europe, which is precisely how we got a shot that was proven to only do damage get mandated everywhere. Only, not really mandated, no one went around forcing injections but if you did not accept, your future was shitting on the streets of San Francisco.

Watch them try to skate their way out of the Covid scam by blaming a fake diploma mill!! Yes, YOU CAN TRUST YOUR DOCTOR, HE'S NOW FULLY VETTED AND WE KNOW HE'S NOT ONE OF THE FAKE ONES THAT KILLED EVERYONE POSSIBLE.​

The plot:

1. Develop a virus for the cover story and a reason to mandate a shot.

2. Develop a shot that sterilizes people while most likely forcing their bodies to produce a wireless system that connects them to the grid and don't worry about the consequences, like blood clots because you won't be getting the shot anyway.

3. Get your ENORMOUS pool of fake doctors and nurses ready to go, because real doctors and nurses tend to have ethics.

4. Cause as many of the existing nurses and doctors to either die from the shot via mandates or quit to avoid the shot. These people will get the worst batches to get rid of them.


5. In the resulting doctor and nurse shortage that "came out of nowhere" (and everyone ought to remember that) - into that void that got created, insert all your fakes, who are really totally un-credentialed murderers. Why would they need credentials if all they are there for is to kill?

6. Encourage the hospitals to stay quiet with enormous payouts for every death, plus enormous payouts for every ventilator hook up, and set the ventilators to kill people by over inflating their lungs. Blame the deaths on covid, because there's tons of bloody lung tissue to blame on a virus. Remember that? how "covid" made the lungs bleed? only no, it was not covid doing that, it was murderers with medical equipment that was set wrong on purpose.

7. Put in place all the social controls you always wanted, in the name of a virus. Lockdowns, social distancing, whatever, while you kill off and sterilize the best and brightest of the WHITE POPULATION with your intentionally sabotaged shots that all the ventilator deaths scared them into getting.

8. Then replace the WHITE POPULATIONwith totally un-checked and encouraged immigration. That will make America and Europe easier to control in the new world order, whites are a big problem for tyranny so just get rid of them.

That is exactly what happened, it was not anything else and everyone knew. The fake doctors and nurses, now admitted to, are the frosting on the cake.​

 

Heliobas Disciple

TB Fanatic
(fair use applies)


NIH Renews Controversial Grant to EcoHealth for Coronavirus Bat Study
By Mark Tapscott
May 8, 2023 | Updated: May 9, 2023

National Institute of Health (NIH) officials have re-activated a previously terminated $576,290 federal grant to EcoHealth Alliance to study how outbreaks of deadly viruses like SARS, MERS, and now COVID-19 originate from wildlife and transfers to humans.

The move has prompted one Republican lawmaker to demand that NIH explain the decision she described as “absolutely reckless.”

“Most emerging human viruses come from wildlife, and coronaviruses in particular represent a significant threat to public health and biosecurity in the U.S. and globally, as was demonstrated by the SARS, MERS, and COVID-19 outbreaks,” is how the NIH describes the purpose of the renewed grant.

The renewed grant is to be administered through the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), the research arm headed for several decades by the recently retired Dr. Anthony Fauci. The description was made public by Rep. Morgan Griffith (R-Va.), who is chairman of the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee.

“This project seeks to understand what factors allow bat-origin coronaviruses, including close relatives to SARS, to jump into the human population by studying their evolutionary diversity, the patterns of spillover in people that live in high-risk communities, and analyzing characteristics of bat coronaviruses that could allow them to emerge,” the grant description continues.

EcoHealth issued a celebratory statement declaring that the NIH decision “reflects a reversal of the previous termination and suspension of a [grant] awarded in 2019, but halted in April 2020 due to concerns about continuing collaborative laboratory research with the Wuhan Institute of Virology (WIH).”

Several U.S. agencies and independent scientists have concluded that a leak from within the WIV lab is the most likely source of the COVID-19 pandemic that, to date, has killed more than 1.1 million Americans since January 2020 and in excess of six million people world-wide.

EcoHealth defenders, including Fauci, have argued that the most likely origin of the COVID-19 virus is through a transference from bats to humans via sale of the creatures’ meat in a market near WIH.

The WIH lab has been the scene of extensive gain-of-function research by Chinese scientists, much of it funded in whole or part prior to the pandemic by NIH grants through EcoHealth. The NIH has awarded seven grants totaling more than $4.1 million to EcoHealth to study various aspects of SARS, MERS, and other coronavirus diseases.

EcoHealth said in its statement that its agreement with NIH requires researchers to conduct all of their studies outside of China and in conjunction with a Singapore-based health facility, as well as other measures designed to address concerns about the lack of proper safety procedures at WIH and its connection with the Chinese military.

“The specific aims have been revised in consultation with NIAID and NIH staff, and respond to any ongoing concerns by removing all on-the-ground work in China and all recombinant virus culture or infection experiments. We have also agreed to all additional oversight mechanisms applied by NIH,” EcoHealth said.

“The renewed work will involve collaboration only between EcoHealth Alliance and the Duke-National University of Singapore Medical School, with the following specific aims: (1) identifying high-spillover risk bat SARSr-CoV sequences in southern China and assessing drivers of recombination; (2) conducting community- and clinic-based surveillance of archived pre-COVID-19 human samples to identify SARSr-CoV spillover events, routes of exposure, and potential public health consequences; and (3) characterizing SARSr-CoV binding, ability to evade therapeutics/vaccines, and identifying spillover hotspots,” the EcoHealth statement continued.

Those revisions may not satisfy congressional critics of NIH’s decade of funding for such research by EcoHealth.

“It’s absolutely reckless that the NIH has renewed a grant for EcoHealth Alliance given their negligence and the breach of their contract with the NIH on the coronavirus research done at the Wuhan Institute of Virology. It is now believed likely that COVID-19 was the result of a lab incident at the Wuhan Institute,” Griffith said in a May 8 statement.

“From my observations, EcoHealth Alliance has not been contrite about their failures. And even worse, they have refused to cooperate with Congress in our attempts to get information about the research they were doing at the Wuhan Institute,” Griffith said.

“Until they can demonstrate a willingness to work with Congress to resolve outstanding questions and fulfill all of the terms of their federal contracts, paid for with American taxpayer dollars, all funding should remain suspended, and no new contracts should be awarded,” he said.

Griffith, alongside House Energy and Commerce Committee Chairman Cathy McMorris Rodgers (R-Wash.) and Subcommittee on Health Chairman Rep. Brett Guthrie (R-Ky.), pushed NIH in an April 25, 2022, letter to Acting Director Lawrence Tabak to investigate EcoHealth President Peter Daszak for multiple alleged failures to comply with federal grant regulations and stipulations.

“Our review of EcoHealth Alliance’s reports about its humanized mice experiments at the Wuhan Institute of Virology (WIV) using funds from the National Institutes of Health (NIH) shows pervasive discrepancies, inconsistencies, and omissions in its progress reports and renewal application that raise serious questions about scientific and ethical misconduct, violations of NIH policies and regulations, and possible false statements and fraud.”

A NIH spokesman did not respond to The Epoch Times’ request for comment.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Raccoon dogs did not start COVID-19, new study says
Alexander Nazaryan·Senior White House Correspondent
Mon, May 8, 2023, 12:51 PM EDT

The raccoon dog did it: That was the explosive takeaway of a genomic analysis conducted in March by a trio of scientists who had scrutinized data from a market in Wuhan, China, where the pandemic was thought to have begun.

Until then, evidence for that conviction had been scant.

“This is a really strong indication that animals at the market were infected,” virologist Angela Rasmussen told the Atlantic, which was first to report on the raccoon dog study. “There’s really no other explanation that makes any sense.”

Others similarly felt it was a landmark moment. For months, momentum had been behind a countervailing hypothesis that a laboratory accident, not an animal, had caused the pandemic. The new raccoon dog analysis appeared to rule out that possibility.

“The COVID lab leak theory is dead,” declared Edward Holmes, one of the researchers involved in the raccoon dog study.

Only his assessment appeared to be premature.

New evidence for market origin

In January, a trove of data from the Huanan Seafood Wholesale Market in Wuhan appeared on the international database GISAID, seemingly by accident. In this batch were genetic samples from swabs taken in market stalls in early January 2020, before most of the world had even heard of the coronavirus.

An evolutionary biologist in France named Florence Débarre spotted the new data and, according to the Atlantic, notified colleagues around the world. With their enormous collection of genetic material from different species, the GISAID samples were a chronicle of the Huanan market in the earliest days of the pandemic. Here, possibly, in the endless string of genetic sequences, lay hidden the origin story of SARS-CoV-2.

Chinese scientists had already analyzed all the Huanan swabs, surmising that “the market may [have] acted as an amplifier of transmission due to the high number of visitors every day.” Their study explicitly discounted the possibility that the virus had jumped from an animal to humans.

Now, working with the raw data, Kristian Andersen, Michael Worobey and Holmes came to an entirely different conclusion. They believed that the pandemic had begun in stall 29, on the southwestern edge of the market.

In that stall sat caged raccoon dogs.

“The Strongest Evidence Yet That an Animal Started the Pandemic,” said the headline of the Atlantic article that broke the news.

A 3-year debate seemingly settled

From the start, the debate about how the pandemic began was as ferocious as it was inconclusive.

At first, pangolins sold at the Huanan market were thought to have been the intermediate species. Bats, which are susceptible to coronaviruses, were another obvious suspect.

Andersen, Worobey and Holmes were part of a group that had maintained from almost the start of the pandemic that only a market origin made sense, a conviction that detractors thought had an oddly dogmatic quality. And for all their confidence, the proponents of a market origin lacked the one thing that could convince skeptics: evidence.

Another group of virologists maintained that a more likely candidate was the nearby Wuhan Institute of Virology, which was well-known to conduct research on bat coronaviruses — and where, in November 2019, three researchers had come down with a mysterious illness.

Biosecurity at the Wuhan institute was reportedly lax (a common problem in Western laboratories as well), making an accident all too plausible.

To the proponents of this lab leak hypothesis, searching for an intermediate species was futile at best, misdirection at worst. Making their case was difficult, however, with then-President Trump regularly launching vituperative attacks on China, baselessly suggesting that the virus was intentionally created as a bioweapon. Few scientists sought association, however indirect, with the likes of Alex Jones and other figures on the conspiratorial fringe.

Still, proponents of a market origin failed to produce any convincing clues, such as a reservoir of animals in the wild infected with the original, “wild type” SARS-CoV-2 strain. It seemed less than plausible that only a single animal had been infected with a virus as highly transmissible as SARS-CoV-2.

The raccoon dog study was, as the Atlantic pointed out, the most persuasive argument in favor of a market origin.

That is, if its conclusions held.

A single molecule among millions


In 2021, computational virologist Jesse Bloom of the Fred Hutchinson Cancer Center gained acclaim (and notoriety) by discovering that coronavirus genetic sequences from the early days of the pandemic had been deleted from a National Institutes of Health archive — at the request of Chinese scientists, it would turn out. Those sequences, Bloom noted in a paper, bore unusual similarity to bat coronaviruses.

Unlike some other researchers looking for the pandemic’s origins, Bloom was not a self-promoter. He did not attack critics on Twitter or make wild, unsupportable claims. “He is the most ethical scientist I know. He wants to dig deep and discover the truth,” a fellow scientist told Vanity Fair.

The raccoon dog revelation gave Bloom a new project. The data used by the Worobey group had been removed from GISAID, only to materialize there again in more fulsome form in late March. Whereas the raccoon dog group had worked with 227 FASTQ files — the format used to store long strings of genetic code — there were 696 FASTQ files in the Huanan sequences that reappeared on GISAID several weeks later.

Working with the bigger database, Bloom processed an astonishing three terabytes of data from the Huanan Market — genetic sequences from the same swabs taken in early 2020 that Worobey and his collaborators thought pointed to raccoon dogs.

Bloom’s analysis did not merely look at where coronavirus and animal genetic material commingled but also at how thorough that commingling had been. And while the Worobey group had only examined mammalian DNA, Bloom sifted through every strand of genetic material, regardless of whether it came from a chicken, a human or a cut of beef.

In a paper published in late April, Bloom wrote that “the samples that contain abundant material from raccoon dogs and other non-human susceptible species generally contain little or no SARS-CoV-2 reads.”

Bloom paid particular attention to sample Q61, which had been collected on Jan. 12, 2020. That day, Chinese investigators had taken 70 samples from the western edge of the market, a hot spot of viral activity, including from the infamous 29th stall that housed raccoon dogs.

Six of those samples had tested positive for SARS-CoV-2. And of the six, a single one — Q61 — also contained the DNA of raccoon dogs, as well as ducks.

It seemed that the raccoon dog claim originated from Q61. But in his own sequencing, Bloom found that out of 200 million “reads,” or discrete viral samples, on the swab, only a single one was positive for the coronavirus. Given that the coronavirus was already spreading throughout Wuhan for several months by then, that particle was far more likely deposited by an unsuspecting human than by a sick animal.

In other words, the Chinese researchers who had been the first to study the swabs, and had concluded that humans carried the virus to the market, appeared to have been correct all along.

As for the raccoon dog, it was unquestionably innocent. “There is a negative correlation between the abundance of SARS-CoV-2 and mitochondrial material from raccoon dogs,” Bloom wrote.

The most viral material came from swabs with DNA from stalls where seafood such as catfish and largemouth bass were sold.

“Obviously largemouth bass did not start the pandemic,” Bloom told Yahoo News. “What these findings suggest is simply that by the time the Huanan market environmental samples were collected, the virus had been spread widely across the market by humans, so colocalization of viral and animal genetic material in samples cannot indicate whether or not any animal was infected.”

Worobey, Andersen and Holmes did not respond to a request for comment. Nor did several other researchers listed as co-authors on the raccoon dog paper. Alexander Crits-Christoph of Johns Hopkins was the sole respondent. He sent Yahoo News an insulting email in response to questions raised by the new study.

So what about the raccoon dog?

From the start, skeptics maintained that there were scant grounds for the assertion that raccoon dogs were the pandemic’s intermediate species, if the only evidence for that claim was the presence of viral and animal DNA in the same market stall.

In a crowded marketplace, there were myriad ways for the DNA of different species to end up in the same place, mixed in with genetic traces of the coronavirus.

“The raccoon dog team made a big fuss out of what is most likely a contaminated sample,” molecular biologist Alina Chan of the Broad Institute of MIT and Harvard told Yahoo News.

“Not only is there no correlation between raccoon dog and virus genetic material, but even the only sample with both raccoon dog and virus was likely cross-contaminated during the sample processing,” she said.

In his paper, Bloom argues that his study does not contradict the raccoon dog hypothesis but, rather, merely points out the near impossibility of using the market swabs to reach any meaningful conclusion about viral origins.

“A careful analysis of these samples does not prove or disprove any particular scenario for how the virus entered the market,” Bloom told Yahoo News, “but does suggest that genetic analysis of the samples is not directly informative for answering that question.”

The media’s role

From the start, the narrative of how the coronavirus originated was a media story, one shaped in large part by attitudes about Trump. The heated and at times ugly rhetoric he deployed at the start of the pandemic — the new virus was a “kung flu,” he was fond of saying in the pandemic’s early days — made it difficult to scrutinize China without fueling what was then a rising tide of animosity toward Asian Americans.

FactCheck.org labeled the notion that the coronavirus originated in a laboratory a “baseless conspiracy theory,” putting credible questions about a lab leak into the same category as obviously untrue claims that the SARS-CoV-2 virus contained strains of HIV.

But then President Biden took office, promising to more thoroughly and systematically address the pandemic — including the question of how it began. Two months into his presidency, he ordered the intelligence community to examine whether the coronavirus could have emerged from a laboratory experiment gone horribly awry.

Several months later, comedian Jon Stewart appeared on Stephen Colbert’s late night talk show. As the conversation turned to the pandemic, Stewart joked about how implausible it was that the virus had originated from animals: “Maybe a bat flew into the cloaca of a turkey and then it sneezed into my chili and now we all have coronavirus?”

Colbert seemed uneasy but Stewart persisted, pointing out that a coronavirus outbreak originating just a few miles away from a laboratory investigating coronaviruses seemed an odd coincidence, at least to him.

“There’s been an outbreak of chocolatey goodness near Hershey, Pennsylvania, what do you think happened? I don’t know, maybe a steam shovel mated with a cocoa bean,” Stewart said with his signature outrage. “Or it’s the f***ing chocolate factory!”

Republicans’ takeover of the House of Representatives the following year all but assured that, even as the pandemic became a background concern for many Americans, its source would remain a topic of intense contention on Capitol Hill — and in the news media.

Chan of the Broad Institute, one of the earliest and most outspoken proponents of a lab leak, told Yahoo News that the raccoon dog controversy was evidence of how badly an authoritative investigation was needed.

“The origin of COVID-19 debate has gotten so fierce that there are solid scientists on both sides who will take any chance to say there is new evidence bolstering their preferred hypothesis,” she said. “A formal commission should be established to bring scientists from both sides to put out a joint analysis of the available evidence. This would help the public to see what the facts are, free from extrapolation and exaggeration.”

She and others faulted the media for continuing to favor the market origin — and for not applying sufficient scrutiny to the raccoon dog claim.

Dissenting opinion

In his paper, Bloom makes no conclusions about how the pandemic began. If anything, he cautions against doing so. “We are unlikely to get conclusive answers about origin of an outbreak that started in Nov 2019 (or earlier) by looking at samples collected in Jan 2020,” he wrote on Twitter.

Still, some scientists have challenged his conclusions.

Frederic Bushman, a University of Pennsylvania microbiologist, told the New York Times that Bloom had set overly “aggressive” thresholds for deeming a sample virus-positive. “I don’t think the Bloom paper changes my thinking that much,” he told the Times.

Christopher Mason, a geneticist at Weill Cornell Medicine, told the Times that Bloom’s analysis may not have fully accounted for the rapidity with which coronavirus RNA may have degraded in the days or even weeks before researchers came to the Huanan market to swab for samples.

Those criticisms underscore how difficult it is to re-create the path SARS-CoV-2 took from a market stall, or a laboratory cubicle, into the human population.

What’s next?

House Republicans are continuing to investigate the origins of the pandemic, though their hearings have thus far yielded little new insight.

Meanwhile, a new report from the COVID Crisis Group (an independent consortium of 34 experts), “Lessons From the COVID War,” argues that “both theories remain plausible” and offer “urgent insights for action.”

Universal laboratory safety guidelines are badly needed, especially when it comes to the riskiest type of viral research. At the same time, the interactions of animals and humans also deserve greater scrutiny. And when an outbreak does occur, open and honest communication is a must.

In effect, both models of how the coronavirus spread should be treated as plausible, because both scenarios will almost certainly materialize during a future outbreak.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Global Study Finds Link Between COVID-19 Vaccination and Menstrual Changes

By Oregon Health & Science University
May 8, 2023

A recent study found a slightly higher risk of heavier periods after COVID-19 vaccination. Researchers emphasize that the changes are small and typically return to normal in the next menstrual cycle.

A new international study finds that women vaccinated for COVID-19 have a slightly higher risk for a heavier period after vaccination.

The study, led by Oregon Health & Science University reproductive health services researcher Blair Darney, Ph.D., M.P.H., and physician-scientist Alison Edelman, M.D., M.P.H., published recently in the British Journal of Obstetrics and Gynaecology. These findings build on prior work from the same research team that first identified an association between COVID-19 vaccines and menstrual cycle changes.

While there is a growing body of evidence demonstrating that COVID-19 vaccination is associated with a small increase in cycle length, other disturbances such as bleeding quantity are less well known. This study aimed to estimate the effect of COVID-19 vaccination on menstrual bleeding quantity among individuals with normal menstrual cycles.

“Menstruation is a routine bodily function and a key indicator of overall health, so it’s crucial that we understand the scope of this issue among the global population,” said Edelman, one of the study’s lead authors. “The more we can understand about these reported changes, the more effectively we’re able to counsel individuals about what to expect with a COVID-19 vaccine and how to make an informed decision about getting vaccinated.”

In a retrospective cohort study, researchers analyzed menstrual cycle data from the fertility tracking app Natural Cycles. The cohort included a total of 9,555 individuals — 7,401 vaccinated and 2,154 unvaccinated — primarily living in the United States, Canada, the United Kingdom and Europe. Participants reported daily bleeding quantity as “spotting,” “light,” “medium” or “heavy.” Researchers then examined the number of heavy bleeding days and total bleeding quantity.

Analyses showed a small — 4% — increase in the percentage of participants who experienced greater total bleeding quantity following the first COVID-19 vaccine dose compared with an unvaccinated comparison group. This difference translates to an estimated 40 additional people per 1,000 normally cycling individuals who experienced more bleeding quantity. Researchers also found that these changes typically resolved by the first post-vaccination menstrual cycle.

The research team emphasizes that these findings shouldn’t be a cause for concern, but should validate the public’s experiences and provide reassurance that, if changes in flow occur with vaccination, they are likely to be small and temporary.

“Experiencing an unexpected change in your menstrual cycle can be alarming,” Darney said. “We hope this research can assure individuals that they are heard and their experiences around menstruation are valid. As was discovered in previous research, these changes at a population level are small, typically resolving in the cycle after vaccination, and generally shouldn’t be a source of anxiety or fear.”

Individuals who notice prolonged changes in menstruation are encouraged to seek guidance from their clinician.

While this study didn’t look at why these changes occur, researchers note that there are several plausible ways in which a vaccine-prompted immune response could cause temporary menstrual changes. However, individuals naturally experience variations in menstrual cycle duration and bleeding patterns, making it challenging to isolate COVID-19 vaccination as a sole cause.

Looking forward, researchers hope to learn more about the biological mechanism of these changes, and will continue to leverage data from cycle-tracking apps to investigate other reported variations in menstruation following vaccination, such as missed cycles, unexpected vaginal bleeding and pain.

Darney, Edelman, and colleagues also will study the effect of COVID-19 disease on the menstrual cycle, suspecting that infection itself creates similar changes to those experienced after vaccination.

Reference: “Impact of coronavirus disease 2019 (COVID-19) vaccination on menstrual bleeding quantity: An observational cohort study” by Blair G. Darney, Emily R. Boniface, Agathe Van Lamsweerde, Leo Han, Kristen A. Matteson, Sharon Cameron, Victoria Male, Juan Acuna, Eleonora Benhar, Jack T. Pearson and Alison Edelman, 10 April 2023, British Journal of Obstetrics and Gynaecology.
DOI: 10.1111/1471-0528.17471

Research reported in this publication was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH Office of Research on Women’s Health (NIH NICHD089957 Supplement).
 

Tristan

Has No Life - Lives on TB
Dr. Campbell discusses the world wide phenomenon of excess mortality.

He has already been censored and blocked from youtube for a period of a week; his time on the tube may be numbered.

He is walking a tightrope here...

Excess deaths in UK rise​

View: https://www.youtube.com/watch?v=EgubA8BF3CM

rt: 15:28


Hopefully he'll take the time to start a channel on an alternative platform, and move his previous videos over as necessary...
 

Tristan

Has No Life - Lives on TB
(fair use applies)


NIH Renews Controversial Grant to EcoHealth for Coronavirus Bat Study
By Mark Tapscott
May 8, 2023 | Updated: May 9, 2023

National Institute of Health (NIH) officials have re-activated a previously terminated $576,290 federal grant to EcoHealth Alliance to study how outbreaks of deadly viruses like SARS, MERS, and now COVID-19 originate from wildlife and transfers to humans.

The move has prompted one Republican lawmaker to demand that NIH explain the decision she described as “absolutely reckless.”

“Most emerging human viruses come from wildlife, and coronaviruses in particular represent a significant threat to public health and biosecurity in the U.S. and globally, as was demonstrated by the SARS, MERS, and COVID-19 outbreaks,” is how the NIH describes the purpose of the renewed grant.

The renewed grant is to be administered through the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), the research arm headed for several decades by the recently retired Dr. Anthony Fauci. The description was made public by Rep. Morgan Griffith (R-Va.), who is chairman of the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee.

“This project seeks to understand what factors allow bat-origin coronaviruses, including close relatives to SARS, to jump into the human population by studying their evolutionary diversity, the patterns of spillover in people that live in high-risk communities, and analyzing characteristics of bat coronaviruses that could allow them to emerge,” the grant description continues.

EcoHealth issued a celebratory statement declaring that the NIH decision “reflects a reversal of the previous termination and suspension of a [grant] awarded in 2019, but halted in April 2020 due to concerns about continuing collaborative laboratory research with the Wuhan Institute of Virology (WIH).”

Several U.S. agencies and independent scientists have concluded that a leak from within the WIV lab is the most likely source of the COVID-19 pandemic that, to date, has killed more than 1.1 million Americans since January 2020 and in excess of six million people world-wide.

EcoHealth defenders, including Fauci, have argued that the most likely origin of the COVID-19 virus is through a transference from bats to humans via sale of the creatures’ meat in a market near WIH.

The WIH lab has been the scene of extensive gain-of-function research by Chinese scientists, much of it funded in whole or part prior to the pandemic by NIH grants through EcoHealth. The NIH has awarded seven grants totaling more than $4.1 million to EcoHealth to study various aspects of SARS, MERS, and other coronavirus diseases.

EcoHealth said in its statement that its agreement with NIH requires researchers to conduct all of their studies outside of China and in conjunction with a Singapore-based health facility, as well as other measures designed to address concerns about the lack of proper safety procedures at WIH and its connection with the Chinese military.

“The specific aims have been revised in consultation with NIAID and NIH staff, and respond to any ongoing concerns by removing all on-the-ground work in China and all recombinant virus culture or infection experiments. We have also agreed to all additional oversight mechanisms applied by NIH,” EcoHealth said.

“The renewed work will involve collaboration only between EcoHealth Alliance and the Duke-National University of Singapore Medical School, with the following specific aims: (1) identifying high-spillover risk bat SARSr-CoV sequences in southern China and assessing drivers of recombination; (2) conducting community- and clinic-based surveillance of archived pre-COVID-19 human samples to identify SARSr-CoV spillover events, routes of exposure, and potential public health consequences; and (3) characterizing SARSr-CoV binding, ability to evade therapeutics/vaccines, and identifying spillover hotspots,” the EcoHealth statement continued.

Those revisions may not satisfy congressional critics of NIH’s decade of funding for such research by EcoHealth.

“It’s absolutely reckless that the NIH has renewed a grant for EcoHealth Alliance given their negligence and the breach of their contract with the NIH on the coronavirus research done at the Wuhan Institute of Virology. It is now believed likely that COVID-19 was the result of a lab incident at the Wuhan Institute,” Griffith said in a May 8 statement.

“From my observations, EcoHealth Alliance has not been contrite about their failures. And even worse, they have refused to cooperate with Congress in our attempts to get information about the research they were doing at the Wuhan Institute,” Griffith said.

“Until they can demonstrate a willingness to work with Congress to resolve outstanding questions and fulfill all of the terms of their federal contracts, paid for with American taxpayer dollars, all funding should remain suspended, and no new contracts should be awarded,” he said.

Griffith, alongside House Energy and Commerce Committee Chairman Cathy McMorris Rodgers (R-Wash.) and Subcommittee on Health Chairman Rep. Brett Guthrie (R-Ky.), pushed NIH in an April 25, 2022, letter to Acting Director Lawrence Tabak to investigate EcoHealth President Peter Daszak for multiple alleged failures to comply with federal grant regulations and stipulations.

“Our review of EcoHealth Alliance’s reports about its humanized mice experiments at the Wuhan Institute of Virology (WIV) using funds from the National Institutes of Health (NIH) shows pervasive discrepancies, inconsistencies, and omissions in its progress reports and renewal application that raise serious questions about scientific and ethical misconduct, violations of NIH policies and regulations, and possible false statements and fraud.”

A NIH spokesman did not respond to The Epoch Times’ request for comment.


Of course they did.

The previous 'work' was very effective.
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=pgYp5pfZrCw


Was Omicron dropped in Southern Africa? What could be the purpose?
Vejon Health
May 9, 2023
14 min 32 sec

Looking at the evolution of Omicron and the links to Africa, the lowest vaccinated part of the world. Why would there need to be a variant coming out of Africa? Botswana says some diplomats found to have Omicron variant came from Europe - Reuters https://www.reuters.com/world/africa/... Join on Substack: https://philipmcmillan.substack.com/
 

Heliobas Disciple

TB Fanatic
Dr. Campbell discusses the world wide phenomenon of excess mortality.

He has already been censored and blocked from youtube for a period of a week; his time on the tube may be numbered.

He is walking a tightrope here...

Excess deaths in UK rise​

View: https://www.youtube.com/watch?v=EgubA8BF3CM

rt: 15:28


Hopefully he'll take the time to start a channel on an alternative platform, and move his previous videos over as necessary...

Thanks for posting this video, I had it on my list to post tonight.

An unrelated note - I think he's shocked he was blocked, he has in the hundreds of thousands of hits per video he must be making a lot of money and if he gets deplatformed it will hurt him financially. I think that's why he has been so careful.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


China's fresh COVID wave raises concern of trading volume slowdown
by Winni Zhou and Jindong Zhang in Shanghai and Tom Westbrook in Singapore
Wed, May 10, 2023, 12:29 AM EDT

SHANGHAI/SINGAPORE (Reuters) - A fresh wave of COVID-19 is spreading through China as people return from public holiday travel, reaching trading floors and raising concern of an impact to trading volume - albeit likely not as pronounced as previous pandemic-induced disruption.

More than half a dozen traders and banking sources told Reuters this week that they or colleagues had contracted the coronavirus recently, or had heard of peers testing positive.

"I think about 10% of people around me have caught it again," said a trader at a foreign bank.

COVID-19 swept through trading floors in capital Beijing and the financial hub of Shanghai in December just as China was reopening its economy after three years of stringent containment measures, with illness and absence thinning trading volume and forcing regulators to reschedule meetings.

Traders said they expected less impact this time.

"There's no longer quarantine of cases and close contacts, so the second wave should just slow down trading efficiency," said a second trader at a foreign bank.

The trader said they had been designated as having close contact with a COVID-19 sufferer and had chosen to work remotely from home as some colleagues had tested positive for the virus.

"Impact from COVID shocks should become smaller and smaller. From reopening experiences in other parts of the world, such a trend is similar," said Tommy Xie, head of Greater China research at OCBC Bank.

In China's interbank market, average daily U.S. dollar/yuan trading volume has slowed only slightly. Daily trading volume was $35.9 billion on Monday, the lowest since April 18 and compared with last month's average of $38.9 billion.

While the World Health Organization has declared COVID-19 as no longer a global health emergency, China's health authority this week said case numbers had risen as travel spiked during the five-day Labor Day break through May 3. Still, the number of severe cases in hospitals did not increase significantly.

Virus transmission naturally increases as crowds gather or due to higher mobility during public holidays, so infection in some areas may rebound slightly, said Liu Qing, an official at the National Administration of Disease Prevention and Control.

"However, chances of regional large-scale outbreaks are not high, and there will be no obvious impact on medical treatment and social operations in the short term," Liu said.

A third person at a foreign bank said they recently tested positive and rested at home for a week, though their employer did not have any specific protocols.

However, at least two lenders - including a major state-owned bank - conducted rapid antigen tests after employees reported feeling unwell, people familiar with the matter said.

"Sooner or later the second wave will arrive. I will take extra care of myself for now," said a fourth trader, who works at a Chinese lender.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Researchers refine estimate of COVID vax-related deaths of young athletes, blast media hypocrisy
Reporters tout credulous explanations for rise in cardiac events, use disingenuous fact-checks to distract, researcher says. Congress correcting false Walensky claim, staffer says.

By Greg Piper
Updated: May 10, 2023 - 12:17am

The mainstream media have provided varying explanations for the unexpected rise in blood clots, cardiac events and early death in the past two years: skipping breakfast, falling asleep in front of the TV, "exposure to a sudden gush of water," napping and high noise levels.

One possibility they continue to rule out or simply ignore: COVID-19 vaccination in populations at negligible risk from SARS-CoV-2 itself.

The authors of a December analysis that found a massive rise in athletes' cardiac-related deaths coinciding with the global vaccination campaign have issued a revised version that more carefully delineates causes and age range in response to scrutiny.

The original version drew wide attention in the wake of NFL safety Damar Hamlin's Jan. 2 on-field collapse from a routine tackle.

One of the authors of the analysis, Italian National Council researcher Panagis Polykretis, also published a blistering response Friday to the media's fixation on "19 words" in the analysis he coauthored with cardiologist Peter McCullough while touting farfetched explanations and ignoring repeated false claims about COVID vaccines by federal officials.

The House Appropriations subcommittee that funds the CDC is taking the initiative to correct a COVID-related falsehood by outgoing Director Rochelle Walensky from a hearing last month.

Initially faulted for contradicting her own agency's from-the-start uncertainty on whether COVID vaccines stop viral transmission, Walensky also falsely claimed the international research collaborative Cochrane "retracted" the summary of the latest results from its ongoing mask metastudy, which affirms face coverings have little measurable real-world impact.

Cochrane's editor-in-chief issued a different interpretation of the results in response to heavy pressure from the media to discredit the authors, but didn't retract their summary.

A committee staffer told University of Oxford epidemiologist Tom Jefferson, the metastudy's lead researcher, it would correct the hearing record at his request and notify members, according to a Friday email posted by former Senate Finance Committee investigator Paul Thacker.

The CDC didn't answer Just the News queries for its response.

McCullough and Polykretis, who researches "neurodegenerative disease caused by protein aggregation," published their research letter calling for "rational harm-benefit assessments by age group" for COVID vaccination in the Scandinavian Journal of Immunology just before Christmas.

That letter was itself responding to criticism of Polykretis' earlier analysis in the same journal of the "antigen presentation process in the immunization mechanism" of COVID vaccines and the need for "biodistribution studies" to determine "in which tissues and organs an injected compound travels and accumulates."

The Christmas paper cited 1,101 publicly reported incidents of cardiac-related deaths in athletes in less than two years as of Dec. 24, which they attributed to GoodSciencing, a blog run by an anonymous "small team of investigators, news editors, journalists, and truth seekers."

That's the same number of deaths reported from 1966-2004 in athletes under 35 (half of whom had "congenital anatomical heart disease and cardiomyopathies") in the European Journal of Cardiovascular Prevention & Rehabilitation, the duo noted.

Then-Fox News host Tucker Carlson touted their analysis, prompting the Associated Press to emphasize the GoodSciencing tracker included all ages and some deaths primarily attributed to other factors, such as cancer.

Polykretis told Just the News at the time he was working on a response. He and McCullough published an updated version in the same journal Feb. 20 that identified the deaths by age range, athletic status and primary cause.

The revised figures: 697 professional or semi-pro athletes "still active in their sport" under age 50 who "collapsed and died due to cardiovascular complications, such as primary cardiac arrest or electromechanical dissociation from suspected venous thromboembolism or other cause." Among those, 558 were under 35.

"Such number of documented events is likely largely underestimated, because of the difficulty to gather data from countries where the script/alphabet is not translatable," the update says, calling for creation of a "research registry for athletes with sudden unexpected cardiac arrest" that includes COVID vaccination data.

The duo also added a new study from Science Immunology that found mRNA boosters induce a "class switch" to worse antibodies, and they updated a section on EuroMOMO data from 27 countries that show "a substantial increase in young age excess mortality since the end of 2021." The mortality-monitoring network's "linear assumptions ... may introduce some bias in cumulating data," the revision says.

In his newsletter Friday, Polykretis apologized for using the unaltered GoodSciencing data while defending it as one of the only sources tracking media reports of fishy athlete deaths.

But the mainstream media used that single sentence "to smear the content of the whole paper," which emphasizes the failure to investigate "the repercussions of the autoimmunological response against human cells expressing non-self proteins" amid the "indiscriminate vaccination" of ever-younger children and the naturally immune, he said.

Polykretis recited a litany of false statements throughout 2021 by Walensky, President Biden, then-White House COVID adviser Anthony Fauci and Pfizer CEO Albert Bourla in which the "fact-checking apparatus" showed little interest.

The mainstream media are responsible for "spreading fear in society" by uncritically parroting COVID death numbers based on nonsensical definitions and telling anxious people they are probably infected despite repeated negative tests, he said.

Polykretis singled out AP for trying to "pervert the meaning" of Pfizer executive Janine Small's admission before the European Parliament that it never tested the vaccine for transmission before its emergency use authorization.

Rather than acknowledge governments imposed vaccine mandates based on the false assumption that they stopped transmission, AP's fact-check said "Pfizer never claimed to have studied" the effect on transmission, so social media posts pointing to Small's testimony were "misleading."

It didn't mention that Bourla told CNBC in May 2021 that Pfizer had yet to find a variant "that escapes the protection of our vaccine." A month after AP's defense of Pfizer, the U.K. pharmaceutical regulator determined Bourla misled the public by portraying COVID as a "severe" risk to children in a BBC interview before approval of the Pfizer vaccine for youth.

The mainstream media have a tendency to "endorse every kind of pandemic policy (regardless its sense), to propagandize vaccination, to minimize any possibility of adverse reactions related to the genetic vaccines, and to normalize heart attacks and sudden deaths among young and healthy people," Polykretis wrote.

"Suddenly, it looks like everything in this world is causing heart attacks and blood clots, except one thing," he concluded.

The Associated Press didn't respond to queries for its response to the updated paper and Polykretis' allegations.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


NIH Renews Controversial Grant to EcoHealth for Coronavirus Bat Study
By Mark Tapscott
May 8, 2023 | Updated: May 9, 2023

National Institute of Health (NIH) officials have re-activated a previously terminated $576,290 federal grant to EcoHealth Alliance to study how outbreaks of deadly viruses like SARS, MERS, and now COVID-19 originate from wildlife and transfers to humans.

The move has prompted one Republican lawmaker to demand that NIH explain the decision she described as “absolutely reckless.”

“Most emerging human viruses come from wildlife, and coronaviruses in particular represent a significant threat to public health and biosecurity in the U.S. and globally, as was demonstrated by the SARS, MERS, and COVID-19 outbreaks,” is how the NIH describes the purpose of the renewed grant.

The renewed grant is to be administered through the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), the research arm headed for several decades by the recently retired Dr. Anthony Fauci. The description was made public by Rep. Morgan Griffith (R-Va.), who is chairman of the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee.

“This project seeks to understand what factors allow bat-origin coronaviruses, including close relatives to SARS, to jump into the human population by studying their evolutionary diversity, the patterns of spillover in people that live in high-risk communities, and analyzing characteristics of bat coronaviruses that could allow them to emerge,” the grant description continues.

EcoHealth issued a celebratory statement declaring that the NIH decision “reflects a reversal of the previous termination and suspension of a [grant] awarded in 2019, but halted in April 2020 due to concerns about continuing collaborative laboratory research with the Wuhan Institute of Virology (WIH).”

Several U.S. agencies and independent scientists have concluded that a leak from within the WIV lab is the most likely source of the COVID-19 pandemic that, to date, has killed more than 1.1 million Americans since January 2020 and in excess of six million people world-wide.

EcoHealth defenders, including Fauci, have argued that the most likely origin of the COVID-19 virus is through a transference from bats to humans via sale of the creatures’ meat in a market near WIH.

The WIH lab has been the scene of extensive gain-of-function research by Chinese scientists, much of it funded in whole or part prior to the pandemic by NIH grants through EcoHealth. The NIH has awarded seven grants totaling more than $4.1 million to EcoHealth to study various aspects of SARS, MERS, and other coronavirus diseases.

EcoHealth said in its statement that its agreement with NIH requires researchers to conduct all of their studies outside of China and in conjunction with a Singapore-based health facility, as well as other measures designed to address concerns about the lack of proper safety procedures at WIH and its connection with the Chinese military.

“The specific aims have been revised in consultation with NIAID and NIH staff, and respond to any ongoing concerns by removing all on-the-ground work in China and all recombinant virus culture or infection experiments. We have also agreed to all additional oversight mechanisms applied by NIH,” EcoHealth said.

“The renewed work will involve collaboration only between EcoHealth Alliance and the Duke-National University of Singapore Medical School, with the following specific aims: (1) identifying high-spillover risk bat SARSr-CoV sequences in southern China and assessing drivers of recombination; (2) conducting community- and clinic-based surveillance of archived pre-COVID-19 human samples to identify SARSr-CoV spillover events, routes of exposure, and potential public health consequences; and (3) characterizing SARSr-CoV binding, ability to evade therapeutics/vaccines, and identifying spillover hotspots,” the EcoHealth statement continued.

Those revisions may not satisfy congressional critics of NIH’s decade of funding for such research by EcoHealth.

“It’s absolutely reckless that the NIH has renewed a grant for EcoHealth Alliance given their negligence and the breach of their contract with the NIH on the coronavirus research done at the Wuhan Institute of Virology. It is now believed likely that COVID-19 was the result of a lab incident at the Wuhan Institute,” Griffith said in a May 8 statement.

“From my observations, EcoHealth Alliance has not been contrite about their failures. And even worse, they have refused to cooperate with Congress in our attempts to get information about the research they were doing at the Wuhan Institute,” Griffith said.

“Until they can demonstrate a willingness to work with Congress to resolve outstanding questions and fulfill all of the terms of their federal contracts, paid for with American taxpayer dollars, all funding should remain suspended, and no new contracts should be awarded,” he said.

Griffith, alongside House Energy and Commerce Committee Chairman Cathy McMorris Rodgers (R-Wash.) and Subcommittee on Health Chairman Rep. Brett Guthrie (R-Ky.), pushed NIH in an April 25, 2022, letter to Acting Director Lawrence Tabak to investigate EcoHealth President Peter Daszak for multiple alleged failures to comply with federal grant regulations and stipulations.

“Our review of EcoHealth Alliance’s reports about its humanized mice experiments at the Wuhan Institute of Virology (WIV) using funds from the National Institutes of Health (NIH) shows pervasive discrepancies, inconsistencies, and omissions in its progress reports and renewal application that raise serious questions about scientific and ethical misconduct, violations of NIH policies and regulations, and possible false statements and fraud.”

A NIH spokesman did not respond to The Epoch Times’ request for comment.

More on this.

(fair use applies)


‘Absolutely Reckless’: NIH Allows EcoHealth Alliance to Resume Coronavirus Research
The National Institutes of Health this week reinstated a controversial federal grant to EcoHealth Alliance to study the risk of bat coronavirus spillover, sparking criticism from lawmakers and bioweapons experts.

By Brenda Baletti, Ph.D.
05/10/23


The National Institutes of Health (NIH) this week reinstated a controversial federal grant to EcoHealth Alliance to study the risk of bat coronavirus spillover.

EcoHealth is a New York-based nonprofit whose stated mission is to develop “science-based solutions to prevent pandemics and promote conservation.”

In 2014, EcoHealth received $3.7 million from the National Institute of Allergy and Infectious Diseases (NIAID) to study the risk of bat coronavirus emergence and the potential for outbreaks in human populations — research that included genetically manipulating coronaviruses to make them more infectious to humans.

At the time, Dr. Anthony Fauci was the director of the NIAID, which operates under the NIH.

Nearly $600,000 of the $3.7 million went to EcoHealth’s collaborator, the Wuhan Institute of Virology in China.
However, in April 2020, under the Trump administration, the NIH terminated EcoHealth’s grant over concerns the organization had violated the grant terms, using U.S. taxpayer money to fund gain-of-function research at the Wuhan lab.

EcoHealth on Monday announced that the NIH reinstated the grant, but with new terms, and that EcoHealth will collaborate with the Duke-National University of Singapore Medical School to study zoonotic coronaviruses “with the aim of being transparent about the study’s goals.”

Peter Daszak, Ph.D. — who secretly collaborated with Ralph Baric, Ph.D., and Fauci to steer the media and scientific community away from questions about whether COVID-19 could have originated in a lab — is EcoHealth’s executive director and principal investigator on the grant.

Rep. Morgan Griffith (R-Va.), who sits on the House Energy and Commerce Committee that found multiple serious violations by EcoHealth of the contractual terms and conditions of the 2014 NIH grant, said the decision to reinstate the grant was “absolutely reckless,” given the organization’s “negligence and breach of their contract with the NIH on the coronavirus research done at the Wuhan Institute of Virology (WIV).”

Francis Boyle, J.D., Ph.D., bioweapons expert and professor of international law at the University of Illinois, told The Defender he wasn’t surprised to see the grant reinstated.

“People involved in this, like EcoHealth Alliance, Fauci, the Biden administration, et cetera, know they have crossed the Rubicon and there is no turning back. And they don’t intend to turn back unless and until we stop them. It’s as simple as that,” he added.

Boyle, who authored the Biological Weapons Convention known as the Biological Weapons Anti-Terrorism Act of 1989 that was approved unanimously by both houses of the U.S. Congress and signed to law by President George Bush Sr., also added:

“Clearly, all this gain-of-function work is offensive biological warfare weapons work in violation of the convention and my biological weapons anti-terrorism act, the penalty for which is life imprisonment.”

In January, the Office of Inspector General in the U.S. Department of Health and Human Services (HHS) released a report outlining missed deadlines, confusing protocols and misspent funds in EcoHealth Alliance’s grant management, particularly as it related to the Wuhan lab.

In response, HHS set new terms for the four-year, now-$2.9 million NIAID grant, under which EcoHealth will receive $576,290 this year.

Under the new terms, EcoHealth is barred from conducting any research in China or collecting any new samples from vertebrates and must implement additional oversight of its finances and accounting practices.

The conditions also prevent EcoHealth from doing any work “involving enhanced potential pandemic pathogens,” although the organization can continue to work with “highly pathogenic agents” or “infectious agent [ S] or toxin[ S]” that may warrant a biocontainment safety level (BSL) of 3 or higher. The Wuhan lab was a BSL-4 lab.

EcoHealth is the recipient of 17 active U.S. government grants totaling more than $50 million, The Epoch Times reported.

Publications like Nature and Science celebrated the reinstatement of the grant. Nature said the research was “essential for preventing the next pandemic.”

Science wrote that the Trump administration called for the cancellation of the grant, “amid unsupported allegations that a lab leak at WIV started the COVID-19 pandemic.”

The origins of the COVID-19 virus continue to be debated, but evidence has emerged over the past several years that the “lab-leak theory” is a plausible hypothesis despite attempts to dismiss it.

Several U.S. agencies, former agency officials and independent scientists have concluded that a Wuhan lab leak most likely caused the COVID-19 pandemic. A U.S. Department of Energy report released in February and a Senate report released in April both arrived at the conclusion that COVID-19 likely stemmed from a lab leak.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Experts call for monitoring of respiratory vaccine after trials suggest possible increase in preterm births
by British Medical Journal
May 10, 2023

Experts have called for further scrutiny of a new Pfizer vaccine given during pregnancy to prevent respiratory infection in infants, after trials of a similar GSK vaccine were stopped after a rise in preterm birth and infant deaths.

Pfizer says its vaccine is safe and effective, but experts contacted as part of an investigation published by The BMJ today, say Pfizer's trial data should be reviewed in light of the signal for preterm births seen in GSK's trial.

Pfizer's maternal RSV vaccine aims to protect infants from severe illness caused by the respiratory syncytial virus (RSV). RSV is very common but can be fatal, especially in young children. In 2019, an estimated 3.6% of all deaths worldwide in children aged 1–6 months were due to RSV, with 97% of these deaths occurring in low and middle income countries.

The vaccine has not yet been approved for use, but a decision by the U.S. Food and Drug Administration is expected by August. The European Medicines Agency is also set to make a decision about the vaccine later this year.

In February 2022, GSK halted vaccination in its phase 3 trials of its maternal RSV vaccine after finding an increased risk of preterm birth in vaccinated mothers, mainly in low and middle income countries.

Pfizer published the results of an interim analysis of its phase 3 trial last month, saying that the vaccine was effective against medically attended severe RSV in children and that no safety concerns were identified.

And while the difference in preterm births in the Pfizer trials was not statistically significant, the results have raised concerns about a possible increase in preterm births, and now experts are calling for further analyses of the data and post-approval monitoring of the vaccine should the FDA approve it.

"My interpretation of all these data is that there may be a safety signal for preterm births that should be followed up on," said Klaus Überla, director of the Virological Institute of the University Hospital Erlangen and member of the RSV working group of the Standing Committee on Vaccination (STIKO), which develops national recommendations for the use of licensed vaccines in Germany.

And a scientist at the National Institutes of Health (NIH) said the Pfizer data should be analyzed using more sensitive measures such as average birth weight and subgroup analyses to detect possible signals.

Meanwhile, Cody Meissner, professor of pediatrics and medicine at the Dartmouth Geisel School of Medicine and consultant in the US Centers for Disease Control and Prevention (CDC)'s maternal RSV working group, predicts that possible adverse effects such as premature births will be "closely monitored" in assessment programs by FDA and CDC. "We need a safe vaccine," he added.

Pfizer did not respond when asked about a possible increase in preterm births associated with its vaccine, but told The BMJ that "no imbalance of neonatal deaths was observed" in its phase 3 trial.

In a linked editorial, researchers point to challenges for RSV vaccine development and the main approaches to protection currently being pursued.

They argue that, while the burden of illness caused by RSV is substantial worldwide, it is particularly important that new vaccines and other prevention strategies are available to infants in low and middle income countries, where the greatest illness and deaths occur.

And they say further research is urgently needed "to identify the best prevention strategies for low and middle income countries, where affordability is paramount and timing of administration is complicated by the lack of predictable seasonal RSV epidemics."
 

Heliobas Disciple

TB Fanatic
(fair use applies)


The WHO Has Changed and Now It is a Threat
By David Bell
May 10, 2023

The director-general of the World Health Organization (WHO) reassures us that the WHO’s “pandemic accord” (or “treaty”) won’t reduce the sovereignty of its Member States. The WHO trusts that these words will serve as a distraction from reality. Those driving the perpetual health emergency agenda are planning to give it more power, and States less. This will happen whenever the WHO designates a “Public Health Emergency of International Concern” (PHEIC), or considers we may be at risk of one.

The WHO’s proposed treaty, taken together with its “synergisticamendments to the International Health Regulations (IHR), aim to undo centuries of democratic reform that based sovereignty with individuals, and by extension their State. The discomfort of facing this truth and the complexities it raises is providing the cover needed to push these changes through. This is how democracy, and freedom, wither and die.

Why It’s Hard to Acknowledge Reality​

Our society in the West is built on trust and a feeling of superiority—we built the institutions that run the world and they, and we, are good. We consider ourselves humanitarians, the public health advocates, the unifiers, and anti-fascist freedom-lovers. We consider our system is better than the alternatives—we are “progressive.”

It takes quite a step for comfortable, middle-income left-leaning professionals to believe that the institutions and philanthropic organizations we have admired all our lives might now be pillaging us. Our society relies on having “trusted sources,” the WHO being one of them. Among others are our major media organizations. If our trusted sources told us we were being misled and pillaged, we would accept this. But they are telling us these claims are false, and that all is well. The WHO’s director-general himself assures us of this. Anyone who thinks rich corporate and private sponsors of the WHO and other health institutions are self-interested, that they might mislead and exploit others for their own benefit, is a conspiracy theorist.

We are all capable of believing the rich and powerful of past ages would exploit the masses, but somehow this is hard to believe in the present. For proof of their benevolence, we rely on the word of their own publicity departments and the media they support. Somehow, malfeasance on a grand scale is always a figment of history, and now we are smarter and enlightened.

Over recent decades we have watched individuals accumulate wealth equivalent to medium-sized countries. They meet our elected leaders behind closed doors at Davos. We then applaud the largesse they bestow on the less fortunate, and pretend all this is fine. We watch as corporations expand across national borders, seemingly above the laws that apply to ordinary citizens. We allowed their “public-private partnerships” to turn international institutions into purveyors of their commodities. We ignored this descent because their publicity departments told us to, becoming apologists for obvious authoritarians because we want to believe they are somehow doing a “greater good.”

While a school child might see through this façade to the conflicted greed beyond, it is much harder for those with years of political baggage, a peer network, reputation and career to admit they have been duped. The behavioral psychologists that our governments and institutions now employ understand this. Their job is to keep us believing the trusted sources they sponsor. Our challenge is to put reality above right-think.

The Remaking of the WHO​

When the WHO was set up in 1946 to help coordinate responses to major health problems issues, the world was emerging from the last great bout of fascism and colonialism. Both these societal models were sold on the basis of centralizing power for a greater good. Those who considered themselves superior would run the world for those less worthy. The WHO once claimed to follow a different line.

Since the early 2000s the WHO’s activities have been increasingly dictated by “specified funding.” Its funders, increasingly including private and corporate interest, tell it how to use the money they give. Private direction is fine for private organizations promoting their investors wares, but it is obviously a non-starter for an organization seeking to mandate medicines, close borders, and confine people. Anyone with a basic understanding of history and human nature will recognize this. But these powers are exactly what the amendments to the International Health Regulations and the new treaty intend.

Rather than consider alternate approaches, the WHO is seeking censorship of opinions not fitting its narrative, publicly denigrating and demeaning those who question its policies. These are not the actions of an organization representing “we the people,” or confident in this ability to justify its actions. They are the trappings we have always associated with intellectual weakness and fascism.

WHO’s Impact on Population Health​

In its 2019 pandemic influenza recommendations, the WHO stated that “not in any circumstances” should contact tracing, border closures, entry or exit screening, or quarantine of exposed individuals be undertaken in an established pandemic. They wrote this because such measures would cause more harm than good, and disproportionately harm poorer people. In 2020, in conjunction with private and national sponsors, it supported the largest wealth shift in history from low to high income by promoting these same measures.

In abandoning its principles, the WHO abandoned millions of girls to nightly rape through child marriage, increased teenage pregnancies and child mortality, reduced childhood education, and grew poverty and malnutrition. Despite most of these people being too young to be troubledby the COVID and already having immunity, they promoted billions of dollars of mass vaccination while traditional priorities such as malaria, tuberculosis, and HIV/AIDS deteriorate. Western media have met this with silence or empty rhetoric. Saving lives does not turn a profit, but selling commodities does. The WHO’s sponsors are doing what they need for their investors, while the WHO is doing what it needs to keep their money flowing.

The New Powers of the WHO​

The IHR amendments will reduce the sovereignty of any WHO Member State that fails to actively reject them, giving a single person (the Director General) direct influence over health policy and the freedom of its citizens is indisputable. It is what the document says. Countries will “undertake” to follow recommendations, no longer simply suggestions or advice.

While the WHO does not have a police force, the World Bank and IMF are on board, and control much of your money supply. The U.S. Congress passed a bill last year recognizing that the U.S. Government should address countries that do not comply with the IHR. We are not witnessing toothless threats, most countries, and their people, will have little choice.

The real power of the WHO’s proposals is in their application for any health-related matter they proclaim to be a threat. The proposed amendments state this explicitly, while the “Treaty” expands the scope to “One-Health,” a hijacked public health concept that can mean anything perceived to be affecting human physical, mental, or social well-being.
Inclement weather, crop failures or the promulgation of ideas that cause people stress; everyday things that humans has always coped with, now become reasons to confine people and impose solutions dictated by others.

In essence, those sponsoring the WHO are manufacturing crises of their own desiring, and are set to get wealthier from other’s misery, as they did during COVID. This under the guise of “keeping us safe.” As the WHO implausibly insists, “no one is safe until all are safe,” so removal of human rights must be broad and prolonged. Behavioural psychology is there to ensuring we comply.

Facing the Future​

We are building a future in which compliance with authoritarian dictates will win the return of stolen freedoms, while censorship will suppress dissent. People who wish to see evidence, who remember history or insist on informed consent will be designated, in WHO parlance, far-right mass killers. We have already entered this world. Public figures who claim otherwise are presumably not paying attention, or have other motivations.

We can meekly accept this new disease-obsessed world, some may even embrace the salaries and careers it bestows. Or we can join those fighting for the simple right of individuals to determine their own future, free from the false public goods of colonialism and fascism. At the very least, we can acknowledge the reality around us.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Some adults 65 and over won’t get new COVID shot. Here’s why — and what experts think
Julia Marnin - Miami Herald
Wed, May 10, 2023, 3:17 PM EDT

Less than half of people 65 and older haven’t gotten the updated COVID-19 vaccines targeting the omicron variant as of May 10.

Now, a survey from Health Canal suggests possible reasons why adults of this age — considered the most at risk of severe COVID-19 by the Centers for Disease Control and Prevention — may not be getting the newer shots.

While most adults 65 and over surveyed said the odds of them getting the updated vaccines made by Pfizer or Moderna are “likely,” 18.93%, or “very likely,” 38.26%, other respondents answered differently.

Other adults, 18.04%, said they were “neutral” on whether they plan to get the newer shots, while 7.33% said it was “unlikely” and 17.44% said it was “very unlikely” they would do so, according to the survey, which involved 1,113 participants.

The survey respondents cited worries about their personal safety as one of the top reasons for both getting or not getting the newer shots.

Their responses were collected on April 22, a few days after the Food and Drug Administration announced that the original COVID-19 vaccines made by Pfizer and Moderna are no longer authorized in the U.S.

The companies’ newer vaccines, which are made up of the original vaccine and a second component targeting the omicron variant, have now become the companies’ main dose for people 6 months and older. Specifically, the second component targets omicron BA.4 and BA.5.
Why are some adults 65 and older not getting the updated shots?

All adults surveyed were previously vaccinated against COVID-19, according to the survey report.

Among the adults surveyed who said it was “unlikely” or “very unlikely” they’d get the updated COVID-19 vaccines, the top five reasons behind this were:
  • Not knowing whether the newly formulated vaccine was safe (40.73%)
  • Worries over potential vaccine side effects (31.05%)
  • Skepticism about the effectiveness about the new vaccines’ formulas (27.82%)
  • Believing they’re still strongly protected against COVID-19 (29.44%)
  • Believing that they’re still strongly protected against a severe COVID-19 infection (20.56%)

Meanwhile, top reasons for getting shots, according to Health Canal, are:
  • Protection from the new omicron variants (88.89%)
  • Protection against severe COVID-19 infection (69.97%)
  • Wanting to protect others (63.02%)
  • Preventing long COVID (60.86%)
  • Following CDC recommendations (53.82%)

The Health Canal survey has some limitations, however, including that most participants surveyed were white with most respondents from California, Florida and Texas.
Safety and side effects of updated, bivalent vaccines

The safety of both Pfizer and Moderna’s bivalent COVID-19 vaccines is based on an FDA analysis of clinical trial data of both companies’ original vaccines, as well as data on an “investigational” bivalent vaccine composed of the original shots’ formula and omicron BA.1.

According to the Department of Health and Human Services and the CDC, the updated COVID-19 vaccines are safe — and while serious side effects are possible, they’re considered rare, just like with any vaccine.

Similar to other vaccines, some side effects from the updated COVID-19 vaccines, according to HHS, include a sore arm and flu-like symptoms, including fever, headaches, body aches, fatigue.

HHS says these are typical signs of an immune system response following the updated vaccine.

Four rare “adverse events” — which can be “caused by the vaccine or can be caused by a coincidental event not related to the vaccine” — were identified by the CDC.

These include:
  • Anaphylaxis (allergic reaction)
  • Thrombosis with thrombocytopenia syndrome
  • Myocarditis and pericarditis
  • Guillain-Barré Syndrome
In January, the CDC reported that, for Pfizer’s updated vaccine, a preliminary, potential safety concern was identified regarding adults 65 and older.

The agency’s Vaccine Safety Datalink discovered for this age group, there may be a potential increase in having an ischemic stroke 21 days after getting Pfizer’s new shot. It was ultimately concluded that it’s unlikely there’s a “true clinical risk” and more investigation is needed.

“Undoubtedly, the risk of a whole series of adverse events, including hospitalization, is much, much greater with COVID-19 than it is from the vaccine,” Dr. William Schaffner, a Vanderbilt University professor specializing in infectious diseases and preventive medicine and a member of the CDC Advisory Committee on Immunization Practices’ Covid-19 Vaccine Work Group, told CNN in January.
Updated vaccines’ effectiveness and protection from COVID-19

In the U.S., an array of different omicron subvariants are currently circulating, as the COVID-19 pandemic has changed over time, CDC data shows.

“It is clear that with the evolution of the virus, the vaccines do not protect from infection, but vaccines do provide excellent immunity that prevents hospitalization and deaths, especially in the elderly,” Dr. Shiv Pillai, a professor of medicine at Harvard Medical School, told Health Canal.

A National Institute of Allergy and Infectious Diseases-supported study found the newer vaccines are more effective than original shots against omicron when examining North Carolina Department of Health and Human Services data.

Researchers studied data on 300,000 North Carolina residents vaccinated with the original booster shot between May through August 2022 compared with data on over 1 million state residents who received the bivalent vaccine between September and December 2022.

Ultimately, it was discovered the newer shots were 62% more effective at preventing a severe COVID-19 illness while the original boosters were only 25% effective.

“In total, the bivalent boosters were 37% more effective in preventing hospitalization and death,” the NIH said of the research.

“A second bivalent dose for individuals 65 years of age and older is supported by data showing the waning of immunity in this population over time and its restoration by an additional dose,” the FDA says.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Decoding Long COVID: NIH Study Exposes the Inner Workings of Neurological Symptoms
By National Institute of Neurological Disorders and Stroke
May 10, 2023

A study at the National Institutes of Health (NIH) involving twelve people with persistent neurological symptoms after SARS-CoV-2 infection found differences in immune cell profiles and autonomic dysfunction. Long COVID symptoms include fatigue, “brain fog,” and sleep disturbances, which can last for months. The study used deep phenotyping to analyze clinical and biological features, and found lower levels of T cells, increased numbers of B cells, and problems with the autonomic nervous system in Long COVID patients. The findings, published in Neurology: Neuroimmunology & Neuroinflammation, contribute to the understanding of Long COVID and may lead to better diagnoses and new treatments.

Findings offer insight into biological mechanisms, pointing to possible treatments.

An NIH study on twelve Long COVID patients found differences in immune cell profiles and autonomic dysfunction, contributing to the understanding of the condition and potentially leading to better diagnoses and new treatments.

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles and autonomic dysfunction. These data inform future studies to help explain persistent neurological symptoms in Long COVID. The findings, published in Neurology: Neuroimmunology & Neuroinflammation, may lead to better diagnoses and new treatments.

People with post-acute sequelae of COVID-19 (PASC), which includes Long COVID, have a wide range of symptoms, including fatigue, shortness of breath, fever, headaches, sleep disturbances, and “brain fog,” or cognitive impairment. Such symptoms can last for months or longer after an initial SARS-CoV-2 infection. Fatigue and “brain fog” are among the most common and debilitating symptoms, and likely stem from nervous system dysfunction.

Researchers used an approach called deep phenotyping to closely examine the clinical and biological features of Long COVID in 12 people who had long-lasting, disabling neurological symptoms after COVID-19. Most participants had mild symptoms during their acute infection. At the NIH Clinical Center, participants underwent comprehensive testing, which included a clinical exam, questionnaires, advanced brain imaging, blood and cerebrospinal fluid tests, and autonomic function tests.

The results showed that people with Long COVID had lower levels of CD4+ and CD8+ T cells—immune cells involved in coordinating the immune system’s response to viruses—compared to healthy controls. Researchers also found increases in the numbers of B cells and other types of immune cells, suggesting that immune dysregulation may play a role in mediating Long COVID.

Consistent with recent studies, people with Long COVID also had problems with their autonomic nervous system, which controls unconscious functions of the body such as breathing, heart rate, and blood pressure. Autonomic testing showed abnormalities in control of vascular tone, heart rate, and blood pressure with a change in posture. More research is needed to determine if these changes are related to fatigue, cognitive difficulties, and other lingering symptoms.

Taken together, the findings add to growing evidence that widespread immunological and autonomic nervous system changes may contribute to Long COVID. The results may help researchers better characterize the condition and explore possible therapeutic strategies, such as immunotherapy.

Reference: “Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection” by Yair Mina, Yoshimi Enose-Akahata, Dima A. Hammoud, Anthony J. Videckis, Sandeep R. Narpala, Sarah E. O’Connell, Robin Carroll, Bob C. Lin, Cynthia Chen McMahan, Govind Nair, Lauren B. Reoma, Adrian B. McDermott, Brian Walitt, Steven Jacobson, David S. Goldstein, Bryan R. Smith and Avindra Nath, 5 May 2023, Neurology: Neuroimmunology & Neuroinflammation.
DOI: 10.1212/NXI.0000000000200097

The study was supported by the Intramural Research Program at the National Institute of Neurological Disorders and Stroke (NINDS) and is part of an observational study taking place at the NIH Clinical Center designed to characterize changes in the brain and nervous system after COVID-19 (NCT04564287).

This work is a part of the National Research Action Plan, a broader government-wide effort in response to the Presidential Memorandum directing the Secretary for the Department of Health and Human Services to mount a full and effective response to Long COVID. Led by Assistant Secretary for Health Admiral Rachel Levine, the Plan and its companion Services and Supports for Longer-term Impacts of COVID-19 report lay the groundwork to advance progress in prevention, diagnosis, treatment, and provision of services for individuals experiencing Long COVID.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Breathing Uneasy: Sleep Apnea Linked With Increased Long COVID Risks
By NYU Langone Health / NYU Grossman School of Medicine
May 11, 2023

Sleep apnea increases the risk of long COVID in adults, according to a study by the National Institutes of Health’s RECOVER Initiative and NYU Langone Health. The study found a 12-75% increased risk for long-term symptoms in adults with sleep apnea, while the risk disappeared in children when accounting for other factors.

Study suggests physicians may need to follow patients with both conditions more closely.

A study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health found that sleep apnea significantly increases the risk of long COVID in adults. The research team analyzed data from over 2 million patients across three networks and found that a prior diagnosis of sleep apnea led to a 12% increase in long-term symptoms in the PCORnet group and a 75% increase in the N3C group. The increased risk persisted even when accounting for other known factors contributing to long COVID, such as obesity, hypertension, diabetes, and hospitalization during initial infection. Interestingly, the risk of long COVID associated with sleep apnea disappeared in children when controlling for other factors.

Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by the National Institutes of Health’s RECOVER Initiative and supported by NYU Langone Health as home to the effort’s Clinical Science Core (CSC).

As of April 2023, more than 100 million Americans had been infected with the virus that causes COVID-19. As of April the U.S. Government’s Household Pulse survey estimated that about 6 percent of U.S. adults are experiencing symptoms associated with long COVID, including brain fog, fatigue, depression, and sleep problems. Past studies have shown that patients with obstructive sleep apnea (OSA) tend to have more severe illness when initially infected with COVID-19. OSA affects about 1 in 8 adults but is often underdiagnosed.

To better understand links between sleep apnea and long-term COVID symptoms, the research team reviewed data across three RECOVER research networks of patients who had tested positive for COVID-19 between March 2020 and February 2022, according to their health records. Two networks included adult patients – the National Patient-Centered Clinical Research Network (PCORnet) with 330,000 patients – and the National COVID Cohort Collaborative (N3C) with 1.7 million patients. The third patient cohort in the study analysis included the pediatric-focused network PEDSnet, made up of 102,000 children.

Published online on May 11 in the journal Sleep, this study found that a prior diagnosis of sleep apnea in the PCORnet group came with a 12 percent increase in risk for long-term symptoms months after patients’ initial infections. In the N3C patient group, in which patients had higher levels of other chronic conditions than those in PCORnet, sleep apnea came with a 75 percent increase in risk for long COVID compared to those without sleep apnea. The observed increases in risk for long COVID in adults with sleep apnea remained significant even when the research team accounted for obesity, hypertension, diabetes, and hospitalization at the time of their initial COVID infection, all known to independently contribute to risk for long COVID.

The researchers hypothesize that the differences in the percentage increases in long COVID risk between the study groups may be further explained by variations in definitions of long COVID, study populations, and in analysis methods of patient records, across the large study. In contrast to the patterns seen in adults, the contribution of sleep apnea to the risk of long COVID disappeared in children when the researchers controlled for other risk factors, including obesity.

“A strength of the work is that the link between sleep apnea and long COVID persisted regardless of how the researchers in our study defined long COVID or gathered data,” says senior study author Lorna Thorpe, PhD, MPH, Professor and Director of the Division of Epidemiology at NYU Langone Health. She is also co-lead of efforts to understand long COVID using electronic health record networks for the RECOVER CSC at NYU Langone. “This study is the first collaboration of this focus and scale to find that adults with sleep apnea are at greater risk for long COVID.”

RECOVER—Researching COVID to Enhance Recovery—is dedicated to understanding why some people develop long-term symptoms following a COVID infection, and how to detect, treat, and prevent long COVID. As the CSC, NYU Langone Health is charged with integrating research activities of clinical sites around the country.

“There’s still so much to uncover about long COVID, but this study will inform clinical care by identifying patients that should be watched more closely,” says corresponding author Hannah Mandel, a senior research scientist for the electronic health record studies arm of the RECOVER CSC at NYU Langone Health. “People with sleep apnea who get infected with COVID should seek early treatment, pay attention to their symptoms, and keep up with their vaccinations to lower the risk of infection in the first place.”

Interestingly, in the N3C study group, long COVID risk was higher among women with sleep apnea compared to men with sleep apnea. Investigators identified an 89% increased likelihood for having long COVID in women, compared to a 59% increased chance for men. The reasons for this are not clear, but women with diagnosed sleep apnea in their medical records may have more severe conditions than men, in part because women with sleep apnea tend to go undiagnosed with OSA for longer.

Reference: “Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health recordbased analysis from the researching coronavirus disease to enhance recovery initiative” 11 May 2023, Sleep.
DOI: 10.1093/sleep/zsad126

The study was funded by RECOVER (OT2HL161847) and received additional support from the National Center for Advancing Translational Sciences (UL1TR002494). For more information on RECOVER, visit RECOVER: Researching COVID to Enhance Recovery. In addition, the CSC at NYU Langone Health is co-led by RECOVER co-principal investigators Stuart D. Katz, MD, Helen L. and Martin S. Kimmel Professor of Advanced Cardiac Therapeutics and founding director of NYU Langone’s heart failure program; Leora Horwitz, MD, director of the Center for Healthcare Innovation and Delivery Science; Andrea B. Troxel, ScD, director of the Division of Biostatistics and professor in the Department of Population Health; and Rachel S. Gross, MD, director of pediatric research for RECOVER CSC and assistant professor of pediatrics and population health at the NYU Grossman School of Medicine and Bellevue Hospital Center.

Along with Thorpe and Mandel, study authors from the NYU Langone Health were Gunnar Colleen, Yu Chen, and Jeff Radwell in the Department of Population Health, Stuart Katz in the Division of Cardiology, Jasmin Divers in the Department of Medicine at New York University Long Island School of Medicine, and Shari Brosnahan in the Division of Pulmonary, Critical Care and Sleep Medicine. Authors at Weill Cornell Medicine included Sajjad Abedian in the Information Technologies and Services Department; Ana Krieger in the departments of Medicine, Neurology and Genetic Medicine; and Mark Weiner in Department of Medicine. At the Children’s Hospital of Philadelphia, authors included L Charles Bailey, Kathryn Hirabayashi, Vitaly Lorman, and Hanieh Razzaghi at the Applied Clinical Research Center. From the University of Colorado’s Anschutz Medical Campus, authors included Melissa Haendel and Julie McMurry of Biomedical Informatics.

Additional co-authors included Margaret Hall, Richard Moffitt, and Yun Jae Yoo in the Department of Biomedical Informatics at Stony Brook University; and Johanna Loomba, Andrea Zhou, and Suchetha Sharma in the Integrated Translational Health Research Institute at the University of Virginia; Nariman Ammar at the University of Tennessee Health Science Center College of Medicine, Tellen Bennett in the Department of Pediatrics at Children’s Hospital Colorado, M Daniel Brannock of the Center for Data Science and AI in Durham, Christopher Chute of Johns Hopkins School of Medicine, Michael Evans of the Clinical and Translational Science Institute at the University of Minnesota, Mady Hornig of Columbia University’s Mailman School of Public Health, Diego Mazzotti of the Division of Pulmonary Critical Care and Sleep Medicine at the University of Kansas Medical Center, Nathan Pajor of the University of Cincinnati College of Medicine, Emily Pfaff of University of North Carolina at Chapel Hill School of Medicine, Susan Redline of Brigham and Women’s Hospital, Elle Seibert of Rose International, Anisha Sekar of the Patient-Led Research Collaborative in Washington, D.C., and Tanayott Thaweethai of Massachusetts General Hospital and Harvard Medical School, and Andrea Zhou of the Integrated Translational Health Research Institute at of the University of Virginia, on behalf of the RECOVER Consortium.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Shrinking Immunity: Obesity’s Role in Rapid COVID-19 Vaccine Protection Decline
By University of Cambridge
May 11, 2023

A study by the Universities of Cambridge and Edinburgh found that COVID-19 vaccine protection declines more rapidly in people with severe obesity, suggesting they may need more frequent booster doses for sustained immunity. This has important implications for global vaccine prioritization policies.

The protection offered by COVID-19 vaccination declines more rapidly in people with severe obesity than in those with normal weight, scientists have found. The study suggests that people with obesity are likely to need more frequent booster doses to maintain their immunity.

Researchers at the Universities of Cambridge and Edinburgh have found that COVID-19 vaccine protection declines more rapidly in people with severe obesity compared to those with normal weight. The study, published in Nature Medicine, indicates that obese individuals may require more frequent booster doses to maintain immunity. While previous studies have suggested that antibody levels are lower in vaccinated people with obesity, this study is the first to show that the ability of antibodies to neutralize the virus declines faster in this group. The findings have significant implications for vaccine prioritization policies worldwide.

Clinical trials have shown that COVID-19 vaccines are highly effective at reducing symptoms, hospitalization, and deaths caused by the virus, including for people with obesity. Previous studies have suggested that antibody levels may be lower in vaccinated people who have obesity and that they may remain at higher risk of severe disease than vaccinated people with normal weight. The reasons for this have, however, remained unclear.

Today’s study, published in the journal Nature Medicine, shows that the ability of antibodies to neutralize the virus declines faster in vaccinated people who have obesity. The findings have important implications for vaccine prioritization policies around the world.

During the pandemic, people with obesity were more likely to be hospitalized, require ventilators, and to die from COVID-19. In this study, the researchers set out to investigate how far two of the most extensively used vaccines protect people with obesity compared to those with a normal weight, over time.

A team from the University of Edinburgh, led by Prof Sir Aziz Sheikh, looked at real-time data tracking the health of 3.5 million people in the Scottish population as part of the EAVE II study. They looked at hospitalization and mortality from COVID-19 in adults who received two doses of COVID-19 vaccine (either Pfizer-BioNTech BNT162b2 mRNA or AstraZeneca ChAdOx1).

They found that people with severe obesity (a BMI greater than 40 kg/m2) had a 76% higher risk of severe COVID-19 outcomes, compared to those with a normal BMI. A modest increase in risk was also seen in people with obesity (30-39.9kg/m2), which affects a quarter of the UK population, and those who were underweight. ‘Break-through infections’ after the second vaccine dose also led to hospitalization and death sooner (from 10 weeks) among people with severe obesity, and among people with obesity (after 15 weeks), than among individuals with normal weight (after 20 weeks).

Prof Sir Aziz Sheikh said: “Our findings demonstrate that protection gained through COVID-19 vaccination drops off faster for people with severe obesity than those with a normal body mass index. Using large-scale data assets such as the EAVE II Platform in Scotland have enabled us to generate important and timely insights that enable improvements to the delivery of COVID-19 vaccine schedules in a post-pandemic UK.”

The University of Cambridge team – jointly led by Dr. James Thaventhiran, from the MRC Toxicology Unit and Prof Sadaf Farooqi from the Wellcome-MRC Institute of Metabolic Science – studied people with severe obesity attending Addenbrooke’s Hospital in Cambridge, and compared the number and function of immune cells in their blood to those of people of normal weight.

They studied people six months after their second vaccine dose and then looked at the response to a third “booster” vaccine dose over time. The Cambridge researchers found that six months after a second vaccine dose, people with severe obesity had similar levels of antibodies to the COVID-19 virus as those with a normal weight.

But the ability of those antibodies to work efficiently to fight against the virus (known as ‘neutralization capacity’) was reduced in people with obesity. 55% of individuals with severe obesity were found to have unquantifiable or undetectable ‘neutralizing capacity’ compared to 12% of people with normal BMI.

“This study further emphasizes that obesity alters the vaccine response and also impacts on the risk of infection,” said Dr. Agatha van der Klaauw from the Wellcome-MRC Institute of Metabolic Science and first author of the paper. “We urgently need to understand how to restore immune function and minimize these health risks.”

The researchers found that antibodies produced by people with severe obesity were less effective at neutralizing the SARS-CoV-2 virus, potentially because the antibodies were not able to bind to the virus with the same strength.

When given a third (booster) dose of a COVID-19 vaccine, the ability of the antibodies to neutralize the virus was restored in both the normal weight and severely obese groups. But the researchers found that immunity again declined more rapidly in people with severe obesity, putting them at greater risk of infection with time.

Dr. James Thaventhiran, a Group Leader from the MRC Toxicology Unit in Cambridge and co-lead author of the SCORPIO study said: “It is promising to see that booster vaccines restore the effectiveness of antibodies for people with severe obesity, but it is concerning that their levels decrease more quickly, after just 15 weeks. This shows that the vaccines work as well in people with obesity, but the protection doesn’t last as long.”

Prof Sadaf Farooqi from the Wellcome-MRC Institute of Metabolic Science and co-lead author of the SCORPIO study said: “More frequent booster doses are likely to be needed to maintain protection against COVID-19 in people with obesity. Because of the high prevalence of obesity across the globe, this poses a major challenge for health services.”

Reference: “Accelerated waning of the humoral response to COVID-19 vaccines in obesity” by A.A. van der Klaauw et al., 11 May 2023, Nature Medicine.
DOI: 10.1038/s41591-023-02343-2
 

Heliobas Disciple

TB Fanatic
(fair use applies)


COVID Was Not Dangerous to Unvaccinated Pregnant Women
Only Nine Pregnant Women Died of COVID-19 in 2020 in the UK

Igor Chudov
May 11, 2023


Remember the endless media hysterics about COVID being “dangerous to unvaccinated pregnant women”?



A recent report MBRRACE-UK throws doubt on such statements. It covers 2018-2020, so the year of 2020 was a part of the COVID pandemic.

In the UK, in 2020 (before COVID vaccines), only NINE women died from (or with) COVID-19 during pregnancy or up to six weeks after giving birth.



Remember that in 2020, all pregnant women in the UK were unvaccinated. COVID was at its worst in 2020.

COVID was quite rampant in the UK at the time. According to Our World in Data, the UK had 94,194 COVID deaths in 2020. However, only nine deaths out of those involved pregnant women.

ONS reports that England and Wales had 613,936 live births in 2020.



So,
  • Pregnant women’s COVID deaths (9 total) were less than one in ten thousand overall COVID deaths.
  • Pregnant women’s deaths (9 total) were less than one in 68,000 (sixty-eight thousand) births.
  • In other words, for every pregnant woman who died of COVID in 2020, over 68,000 did NOT die.
Every death is a tragedy, especially those of future mothers. Those nine deaths were tragic for the families involved. I am very sorry for each of the nine women who died with COVID in the UK in 2020. I am relieved, however, that the number of deaths among pregnant women was far less than what the media intimated.

Was COVID a great danger to pregnant women? The numbers above suggest that the chance of dying from COVID for unvaccinated women in 2020 was very remote, as there was less than one COVID death per 68,000 births.

To me, this cannot be considered “particularly dangerous.” Pregnant women are young (most are under 40), and Covid is not particularly deadly to that age category.

So, those who believed that COVID-19 puts future mothers’ lives at tremendous risk were lied to. Pregnant women were given false information to nudge them to get vaccinated.

We finally have the proof.

What do you think?
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Florida's Letter to the CDC and the FDA Exposes Vaccine Quackery
Will Joe Ladapo Become the Next U.S. Surgeon General after a "regime change"?

Igor Chudov
May 11, 2023

Florida’s Surgeon General Joseph Ladapo sent an open letter to the FDA and the CDC. The letter asks all the right questions about COVID vaccines - and exposes the FDA and the CDC as charlatans engaging in medical quackery.

Here’s the letter:




A very nice statement at the bottom summarizes the state of things:

Ladapo: Your organizations are the main entities promoting vaccine hesitancy - Florida promotes the truth. It is our duty to provide all information within our power to individuals so they can make their own informed health care decisions. A lack of transparency only harms Americans’ faith in science.

Vaccine Medical Quackery​

Reminder: promoting unproven, untested, and non-working medications is called medical quackery, and promoters of such are called charlatans.

Ladapo exposes this medical quackery by asking several questions, each showing that the FDA (and the CDC) attempted to hide facts that reveal the dangers and ineffectiveness of Covid vaccines. Summary follows:

  • Why were randomized clinical trials not conducted for “Covid boosters” (such trials were necessary to establish that they are safe and effective)
  • Why did the FDA ignore many subclinical myocarditis reports and allow Pfizer to postpone its report on subclinical myocarditis?
  • Why were vaccine side effects intentionally ignored in V-Safe?
  • Why did the FDA allow Pfizer to hide the results of its clinical trial of Covid vaccines in pregnant women, that ended in 2022?
  • Why are the FDA and the CDC hiding negative effectiveness of Covid vaccines?
All these questions demonstrate that the FDA and the CDC intentionally conspired with vaccine manufacturers to hide adverse events of Covid vaccines and violated their own rules.

Covid Reckoning Instead of “Pandemic Amnesty”

The questions, growing more pointed daily, show that the long-hoped-for Covid reckoning is coming, as I explained:

May 1
I am thrilled to report that the “Covid reckoning” we hoped for is underway. The state of Texas is joining the bandwagon. The day's news is that Texas Attorney General Ken Paxton is opening an investigation into fraud committed by Pfizer and others. Texas Attorney General’s office will try to find out


Florida’s Surgeon General, Dr. Ladapo, is working hard to protect Floridians from Covid vaccines. However, he is not stupid and probably angling to become the next United States Surgeon General.

Asking questions such as the above will hopefully help enact “regime change” and allow new players, not tarnished by reckless “Warp Speed” vaccine programs or by vaccine mandates, to take over.

While I do not expect an honest answer from the FDA or the CDC, I wish Dr. Ladapo all the best and hope to see him appointed the US Surgeon General in 2024
 

Heliobas Disciple

TB Fanatic
(fair use applies)


FBI Contractor Created Fake Online IDs to Join Chatrooms Run by Groups Organizing Against Vaccine Mandates
An FBI surveillance contractor infiltrated the chatrooms of two airline industry groups opposed to vaccine mandates to collect intelligence on the groups’ organizing activities, investigative journalist Lee Fang reported.

By Brenda Baletti, Ph.D.
05/12/23

An FBI surveillance contractor infiltrated the chatrooms of two airline industry groups opposed to vaccine mandates to collect intelligence on the groups’ organizing activities, investigative journalist Lee Fang reported.

The contractor, Flashpoint, which in the past infiltrated Islamic terror groups, now focuses on “anti-vaccine” groups and other domestic political organizations, according to Fang.

In a webinar presentation for clients last year, which Fang analyzed on his Substack, Flashpoint analyst Vlad Cuiujuclu demonstrated his company’s methods for identifying and entering encrypted Telegram chat groups.

He explained how the company attempted to join chatrooms of transportation workers resisting the COVID-19 vaccine mandates.

Fang described the presentation:

“‘In this case, we’re searching for a closed channel of U.S. Freedom Flyers,’ said Cuiujuclu. ‘It’s basically a group that opposed vaccination and masks.’

“As he clicked through a database, Cuiujuclu showed a chat group on Telegram sponsored by Airline Professionals For Justice, another group formed by airline industry workers opposed to the mandate. The forum, he added, provided useful insights, including Zoom links for meetings of the grassroots organization.

“‘Private chats,’ said Cuiujuclu, ‘require for you to have an invite link,’ which he noted can often either be found by scrolling through public forums or by ‘engag[ing] the admin of that channel.’”

Flashpoint also offers clients artificial intelligence and internet scraping tools.

According to Fang, the firm is a leader in the “threat intelligence industry,” a growing number of security and surveillance firms that create fake online identities to infiltrate Discord chats, WhatsApp groups, Reddit forums and dark web message boards to gather information for clients, including corporations and the FBI, to monitor potential threats.

Joshua Yoder, president of US Freedom Flyers, said he is aware that Flashpoint infiltrated private chat groups associated with his organization.

Yoder told The Defender:

“Tradecraft and other strategies are often used to gain inside knowledge of conservative organizations with the intent to disrupt, mislead and otherwise thwart effective campaigns.

“Infiltration is a tactic used by the deep state to prevent the truth from being told by attempting to destroy the advancement of the message. The team at US Freedom Flyers has been successful in recognizing these attacks and we have taken decisive actions to protect the organization and our members.”

Aviation industry workers were some of the most vocal and organized against COVID-19 vaccine mandates.

They wrote an open letter to the aviation industry signed by thousands of organizations, physicians and pilots. They also organized research on the risks of vaccines for pilots, spoke publicly about the “culture of fear and intimidation” around the mandates in the industry, and filed multiple lawsuits in Canada, the Netherlands, and the U.S.

US Freedom Flyers brought a lawsuit against Atlas Air, one of the largest air cargo carriers in the aviation industry, in May 2022.

Fang told The Defender the targeting of American citizens resisting the vaccine mandates fits into a long history of surveillance being used to subvert democracy. He said:

“There is a long sordid history of informants and surveillance contractors working to undermine democratic engagement in this country.

“The push against regular citizens opposed to COVID-19 vaccine mandates has come in many forms: censorship, demonization and in this case, surveillance.”

The growing market for spying on domestic dissent

Flashpoint advertises its surveillance success on its website, providing examples of its work undermining environmental activism, G20 protests and protests against the aviation industry.

The webpages describing these activities were taken down after Fang published his investigation, but they can be found on the Wayback Machine internet archive.

For example, Flashpoint described its capacity to monitor activists organizing against pollution and the aviation industry. The website said:

“By monitoring the situation and assessing tactics, techniques, and procedures (TTP’s), Flashpoint was able to assess the impact of upcoming protests, and determine that these groups would likely continue to protest and attempt to impede airport construction and expansion projects through direct action. …

“Based on this information, Flashpoint customers were able to take actions to help control the impact to business operations, and to ensure the safety of their employees and facilities as well as the safety of those protesting.”

Flashpoint was founded by Evan Kohlmann, former NBC News contributor who investigated Islamic terror groups and whom The Intercept described as “the U.S. government’s go-to expert witness in terrorism prosecutions.”

Jack Poulson of Tech Inquiry, a group that researches the surveillance industry, told Fang that “Flashpoint has been selling its chatroom infiltration services to companies and governments for years.”

But, he said, it has shifted its focus from “surveilling Muslims after September 11” and “followed the money into both the Pentagon’s information warfare programs and the business of monitoring domestic protest groups.”

Last year, Flashpoint acquired Echosec Systems, another intelligence contractor, and last month it formalized a partnership with Google Cloud.

These acquisitions come in addition to “a steady stream of contracts to Flashpoint in recent years from the FBI, the Department of Defense, Treasury Department, and Department of Homeland Security, among other agencies,” Fang wrote.

Fang also spoke to Jay Bhattacharya, M.D., Ph.D., professor of medicine at Stanford University, research associate at the National Bureau of Economics Research and one of the authors of the Great Barrington Declaration.

Bhattacharya said:

“This kind of domestic spying violates the implicit protection Americans have in these kinds of settings.

“This isn’t terrorism, this doesn’t have anything to do with national security.

“This is a private set of employees, workers who are trying to maintain their jobs in the face of unscientific demands for COVID vaccinations.”
 
Top